Systems Theory-Driven Framework for AI Integration into the Holistic Material Basis Research of Traditional Chinese Medicine

Jingqi Zeng , Xiaobin Jia

Engineering ›› 2024, Vol. 40 ›› Issue (9) : 30 -54.

PDF (5151KB)
Engineering ›› 2024, Vol. 40 ›› Issue (9) :30 -54. DOI: 10.1016/j.eng.2024.04.009
Research
Review
Systems Theory-Driven Framework for AI Integration into the Holistic Material Basis Research of Traditional Chinese Medicine
Author information +
History +
PDF (5151KB)

Abstract

This paper introduces a systems theory-driven framework to integration artificial intelligence (AI) into traditional Chinese medicine (TCM) research, enhancing the understanding of TCM’s holistic material basis while adhering to evidence-based principles. Utilizing the System Function Decoding Model (SFDM), the research progresses through define, quantify, infer, and validate phases to systematically explore TCM’s material basis. It employs a dual analytical approach that combines top-down, systems theory-guided perspectives with bottom-up, elements-structure-function methodologies, provides comprehensive insights into TCM’s holistic material basis. Moreover, the research examines AI’s role in quantitative assessment and predictive analysis of TCM’s material components, proposing two specific AI-driven technical applications. This interdisciplinary effort underscores AI’s potential to enhance our understanding of TCM’s holistic material basis and establishes a foundation for future research at the intersection of traditional wisdom and modern technology.

Graphical abstract

Keywords

Artificial intelligence / Systems theory / Traditional Chinese medicine / Material basis / Bottom-up

Cite this article

Download citation ▾
Jingqi Zeng, Xiaobin Jia. Systems Theory-Driven Framework for AI Integration into the Holistic Material Basis Research of Traditional Chinese Medicine. Engineering, 2024, 40(9): 30-54 DOI:10.1016/j.eng.2024.04.009

登录浏览全文

4963

注册一个新账户 忘记密码

The human body, an open and intricately complex system, displays distinct responses to varied medical interventions. Traditional Chinese medicine (TCM), rich in historical and cultural significance, offers a unique perspective on the intricate relationship between the human body and nature. Integrating distinct philosophical foundations, diagnostic methods, and therapeutic practices [1], [2], TCM has become a leader in addressing diseases like influenza, utilizing its extensive clinical experience and comprehensive strategies [3]. The role of TCM was particularly highlighted during the coronavirus disease 2019 (COVID-19) pandemic in 2019 [4], [5], [6], where it played a pivotal role, underscoring its importance on the global health stage. At its core, TCM advocates for a holistic treatment approach, which not only acknowledges the complexity of illnesses but also mirrors the deep philosophical insights and substantial practical knowledge accumulated within this medical tradition
In stark contrast to contemporary biomedicine, TCM’s perspective on health and disease significantly deviates in terms of underlying philosophies, terminologies, and methodologies for diagnosis and treatment [7]. TCM research is increasingly embracing scientific methodologies, incorporating computational modeling and data analysis [8], [9]. This shift calls for a systematic investigation into TCM’s material basis to streamline its complex theoretical constructs into a coherent knowledge system. The term “material basis” refers to the chemical constituents that form a medicinal substance or compound, delivering therapeutic effects through their synergistic, multi-target, and multi-pathway mechanisms. Understanding the material basis is crucial for both guiding clinical practices and facilitating new drug discoveries, as exemplified by artemisinin [10].
Merging traditional TCM insights with modern scientific approaches, while preserving holistic herbal medicine principles and meeting strict evidence-based criteria, presents considerable challenges. Research into the material basis of TCM spans a multifaceted domain, encompassing various dimensions and levels. Artificial intelligence (AI), through mimicking human cognitive functions, provides potent solutions for complex challenges. However, the intersection of AI with TCM’s holistic material basis research, particularly its application in deep analysis, remains underexplored. To this end, this study introduces an innovative research framework based on systems theory—the System Function Decoding Model (SFDM), involves four main steps: define, quantify, infer, and validate. The primary objective of this research is to optimize the study of TCM’s holistic material basis through AI, focusing on quantification and inference processes.

1. Integrating AI into holistic material basis research of TCM through SFDM

1.1. Unveiling the complexities of TCM’s holistic material basis

The material foundation of TCM comprises a complex network of bioactive compounds such as alkaloids, glycosides, polysaccharides, and essential oils, each contributing uniquely to TCM’s therapeutic efficacy. A profound understanding of TCM’s material basis involves more than identifying and quantifying these compounds; it requires a comprehensive examination of their physicochemical properties, intermolecular interactions, and collective impact on the body’s pharmacokinetic (PK) and pharmacodynamic (PD) activities. Such an in-depth approach is essential for the development of precise medicinal formulations and therapeutic protocols that consider individual differences, such as genetic makeup, age, and gender.

Modern research into TCM’s holistic material basis adheres to a principle against isolating components, emphasizing synergistic interactions that reflect TCM’s holistic philosophy. This view advocates that the efficacy of TCM formulations derives from the synergistic interactions among its constituents, mirroring TCM’s holistic philosophy. This research examines the full spectrum of TCM’s chemical constituents and their interactions within the body, affecting drug absorption, distribution, metabolism, excretion (ADME), and their combined impact on various biological targets. Exploring TCM’s holistic material basis bridges interdisciplinary fields such as pharmaceutics, pharmacology, systems biology, and precision medicine. It aims to elucidate the intricate relationships between TCM components at molecular and systemic levels, accounting for variabilities from individual to population scales, thereby uncovering the unique mechanisms and therapeutic potentials of TCM.

1.1.1. Comparative analysis of research strategies

Fig. 1 illustrates a comparative analysis of the top-down and bottom-up approaches in TCM material basis research. The Top-Down Scientific Discovery framework begins with a comprehensive layer, “formula” and incrementally narrows down to the “herbal,” “component,” and finally, the “ingredient” levels. This phenotype-driven discovery pathway starts with the formula’s observable effects, systematically isolating active ingredients through chemical separation and activity tracing.

In contrast, the Bottom-Up Scientific Innovation framework starts from the molecular “target” and “dose-response relationship,” ascending to “drug combinations” and “syndrome.” This method focuses on molecular interactions, aiming to decode TCM’s essence from the foundational level. It concentrates on ADME, toxicity, and the in vitro-in vivo correlation (IVIVC), thereby elucidating the underlying topological dynamics of syndromes. While the top-down approach seeks to simplify TCM’s complexity by deconstructing its formulas to elemental constituents, the bottom-up strategy endeavors to maintain TCM’s integrity, constructing a detailed understanding from the molecular level.

1.1.2. Top-down approach

Inspired by a reductionist philosophy, the top-down approach in TCM research methodically deconstructs formulations from broad to detailed perspectives to elucidate their mechanisms and efficacy. It starts with an overarching analysis of the effects of formulations, advancing to the separation of chemical and biological components, setting the stage for the identification and pharmacological exploration of individual compounds. Techniques like metabolomics [11], [12], TCM syndrome metabolomics [13], gene expression profiling, and whole-genome chip assays [14] are crucial for deepening the understanding of TCM’s mechanisms. Furthermore, immunoaffinity chromatography [15] uniquely facilitates the selective removal of multiple components in TCM formulations. Despite its proficiency in isolating and identifying pharmacologically active substances, the top-down approach requires enhancements in its in-depth pharmacological analysis and overall mechanism exploration of formulations for improved efficacy.

1.1.3. Bottom-up approach

In contrast, the bottom-up approach uses bioinformatics and computational analysis to create a “component-target-disease” framework that investigates the synergistic effects of TCM components. It uses an interdisciplinary methodology, incorporating chemoinformatics and bioinformatics [16], to identify potential active molecules, and employs molecular docking [17] to predict TCM’s active components and understand their mechanisms. Supportive databases like CPMCP [18], SymMap [19], TCMSP [20], ETCM [21], TCMID [22], SuperTCM [23], TCMBank [24], HERB [25], and CMAUP [26] underpin this research. Network pharmacology [27] is extensively applied in this context to deepen the comprehension of TCM’s holistic efficacy and to chart new paths for understanding component interactions. However, this approach encounters challenges such as the potential for data oversimplification and homogenization. Additionally, the discovery of new drugs through target detection methods [28] has been limited, especially in treating complex diseases where single-target strategies may not yield the anticipated therapeutic outcomes.

1.2. AI: A brief overview

AI, a rapidly evolving computer science field, is driven by advancements in big data, computational hardware, and algorithmic innovations. It aims to equip machines or software with the ability to perform tasks requiring human intelligence, ranging from basic automation to complex decision-making processes. The AI research domain is extensive, including subfields like machine learning (ML), natural language processing (NLP), computer vision, and robotics, which enable computer systems to replicate human cognitive functions such as learning, reasoning, and self-correction.

Fig. 2 illustrates AI’s multidisciplinary role in scientific research, integrating experimental, theoretical, computational, and data-driven paradigms to address complex challenges. AI applications in scientific research involve data collection, information extraction, and intelligent decision-making, relying on a synergy of computer software technology, mathematical statistics, and substantive expertise. In contemporary scientific research, AI has become crucial for analyzing and addressing complex issues across disciplines, from biology to meteorology. AI methodologies are broadly categorized into end-to-end data-driven models and mechanistic models, reflecting AI’s diverse applications and its pivotal role in enhancing our understanding and management of complex systems and phenomena.

1.2.1. End-to-end data-driven models

These models excel at transforming raw data directly into final outputs, eliminating the need for manual data processing or feature extraction, and are ideal for managing large and complex datasets. They autonomously learn to identify critical patterns and structures. For instance, the AlphaFold deep learning model has revolutionized our understanding of protein structures by accurately predicting their three-dimensional (3D) shapes, using a comprehensive database of known protein structures [29]. Furthermore, in NLP, models like ChatGPT have demonstrated remarkable proficiency in understanding and generating human language, contributing to advancements in areas such as cancer diagnosis and treatment planning [30].

1.2.2. Mechanistic models

Contrasting with data-driven approaches, mechanistic modeling relies on established scientific principles to develop predictive models, often grounded in quantitative theories from physics, chemistry, or biology. These models seek to elucidate and forecast the behaviors of complex systems. For instance, weather forecasting models utilize atmospheric physics to predict climatic changes with significant accuracy [31]. In healthcare, mechanistic models are invaluable for predicting disease progression and enhancing diagnostic processes. For example, AI-enhanced image analysis has demonstrated potential in improving breast cancer detection rates and reducing false positives [32]. Moreover, these models can incorporate individual patient data, including historical health records, biomarker profiles, and treatment responses, to offer personalized disease progression forecasts. Bayesian models are particularly notable for their application in clinical prognosis and diagnostic accuracy improvements [33].

1.3. SFDM and AI in TCM research: A systems theory approach

Integrating AI into TCM holistic material basis research introduces significant challenges due to TCM’s reliance on a holistic, experientially driven framework that defies straightforward quantification. TCM formulations, characterized by their complexity from multiple constituents to diverse therapeutic pathways, demand analytical methods that can encompass this multifaceted nature. Effective AI application in TCM requires models that are deeply rooted in TCM principles and capable of analyzing beyond mere constituent quantities to understand their collective biological mechanisms.

To navigate these complexities, we use a systems theory framework (Fig. 3), viewing TCM as the interaction between two complex systems: TCM formulations and the body’s response systems. This perspective frames the clinical use of TCM as a dynamic interplay of material, energy, and information flows. The “material flow” encompasses TCM’s comprehensive material basis, including both the medicinal constituents and the physiological reactions they trigger. Following the “drug-properties theory of TCM” and the “eight principles of TCM syndrome,” TCM formulations are made from diverse natural ingredients and administered through various methods, including oral, inhalational, and transdermal routes. These interact with the body’s system through processes of PK and PD, aiming for therapeutic efficacy.

1.3.1. Decoding complex systems in TCM with SFDM

Grounded in systems theory, SFDM decodes complex systems by systematically examining how interactions among components yield emergent properties not evident in individual parts. This approach addresses the limitations of traditional linear research methods in capturing the dynamic complexity of systems, making it especially relevant for the holistic material basis study of TCM.

Define: This foundational research step identifies key components, issues, and system boundaries, integrating TCM theory, biomedicine, and systems biology to outline the system’s structure and critical factors such as chemical properties, pharmacological targets, and human metabolism. This step establishes a multidimensional framework for TCM’s holistic material basis.

Quantify: This step converts qualitative relationships into quantitative models using analytical technologies and AI to measure components and interactions. This phase involves building mathematical models to represent the system’s structure and dynamics, utilizing AI for data processing and model construction.

Infer: This phase leverages AI’s predictive capabilities to simulate potential system behaviors and outputs under various scenarios. Techniques like molecular dynamics simulations and bioinformatics are used to predict drug-target interactions and pathways, with AI algorithms enhancing prediction accuracy.

Validate: This involves using experimental or clinical data to test the reliability of inferences and adjust models based on feedback to align predictions with observed results. This iterative process ensures model validity and effectiveness.

SFDM transcends disciplinary boundaries, offering a comprehensive framework for TCM research. It integrates AI with traditional TCM theories and methods, promoting the synthesis of multidisciplinary knowledge and facilitating a deeper understanding of TCM’s holistic material basis.

1.3.2. Objectives and scope of the study

The primary goal of this study is to construct a systematic framework that harnesses AI to bolster the research into the material basis of TCM. This entails addressing the inherent challenges associated with integrating AI into the complex dimensions of TCM through the implementation of the SFDM, which is articulated through phases of definition, quantification, inference, and validation. This investigation delineates the role and function of TCM theoretical principles within complex systems under a systems theory framework, merging TCM research with contemporary medical knowledge. It elaborates on the practical advancements of AI in the domains of TCM material basis quantification, and inference, transforming AI from merely a tool for data processing to a powerful ally in comprehending and applying traditional TCM knowledge. This research spans AI, systems science, and TCM, demonstrating a multidisciplinary effort and setting a pioneering benchmark for incorporating AI into TCM research.

In refining the objectives, the study accentuates a multidimensional comprehension of the material basis system in the definition phase, advocating for a robust theoretical exposition of TCM from dual perspectives: a top-down, system theory-guided approach, and a bottom-up, elements-structure-function-based approach. This dichotomy enables a thorough exploration of TCM’s material basis, covering everything from active substances and biopharmaceutical regulators to drug combinations, self-assembly mechanisms, and remote control. Additionally, the research explores AI’s capabilities in the quantitative assessment of TCM’s material basis and its predictive proficiency in inference analysis. This encompasses evaluating AI’s effectiveness in modeling the complex interactions among TCM elements and forecasting system behaviors from quantitative data, accompanied by two specific technical proposals for AI application material basis research.

2. Systems theory-guided top-down research framework in TCM

This section outlines a comprehensive, systems theory-guided framework for TCM research, streamlining and simplifying TCM’s intricate aspects through a structured, top-down approach. By integrating AI into this methodology, the study seeks to enhance the understanding and application of TCM’s material basis, formulation design, mechanisms of action, clinical positioning, and interaction with external conditions.

As depicted in Fig. 4, this structured top-down approach maps the system from macro to micro levels, integrating contemporary medical insights, and outlines a hierarchical structure focusing on elements, structure, function, boundaries, and environment. This framework not only provides clarity to the fundamental questions of “who,” “why,” “what,” “which,” and “where” in TCM but also furnishes AI with a defined research trajectory. It enhances AI’s capacity to parse and simulate the complex mechanisms of action between TCM formulations and TCM syndromes, establishing a novel methodology for TCM research.

2.1. Elements—Who: Material basis

“Elements” are the foundational components within a system, signifying the various chemical constituents that comprise Chinese herbs, known as the “material basis.” This segment starts with the macro level of herbal materials, progressively narrowing down to the micro level of chemical components and individual ingredients, highlighting their collective role in the system’s overall functionality.

2.1.1. Herbal materials

Herbal materials, including natural plants such as licorice [34], ginseng [35], and Astragalus [36], and those derived from animals [37], minerals [38], and fungi [39], offer rich resources for TCM formulations. The type of herbs, the season of harvest [40], the growing environment [41], and the processing methods [42] can all affect their medicinal properties. The combination and proportion of these herbs form the foundation of TCM formulations, allowing us to understand the relationship between Chinese medicine and syndromes at a holistic level.

2.1.2. Components

Each herb contains multiple chemical components like flavonoids [43] and saponins [44], which are the material carriers of the herb’s therapeutic actions. The diversity of these components in herbs and the subtle variations in their interactions determine their synergistic effects in TCM formulations. Therefore, an analysis at the component level provides us with a scientific basis for understanding complex Chinese herbal formulations from a chemical perspective.

2.1.3. Ingredients

We further investigate the individual ingredients that constitute these chemical components. Although not all individual components are directly involved in the medicinal effect, certain specific active molecules, such as quercetin [45], chlorogenic acid [46], and emodin [47], are of particular interest due to their significant pharmacological activity. These active molecules play key roles in TCM formulations and have become a focus of extensive research.

For example, the classic TCM formula Danggui Buxue Tang, which treats symptoms of qi and blood deficiency, primarily features Angelicae Sinensis Radix and Astragalus. Danggui Buxue Tang contains a variety of active components such as saponins and flavonoids [48]. Among them, Astragalus saponin IV is present in the most abundant quantity at specific extraction ratios, thus exerting the optimal therapeutic effect [49].

2.2. Structure—Why: Formulation design

“Structure” investigates the relationships and functional interactions among these elements, forming the system’s architecture. It delves into the holistic complexity of Chinese herbal medicine, its component interactions, and compatibility with the human body, aiming to unravel the logic and dynamics within herbal formulations and their profound interactions with TCM symptoms.

2.2.1. Herbal compatibility

The combination of herbal formulas adheres to the TCM principle of “monarch, minister, assistant, and courier,” reflecting a deep understanding of the synergistic and potentiation mechanisms of herbs and the holistic treatment philosophy [50]. In clinical practice, although the compositions of TCM formulas are complex, certain herbs are commonly combined due to their complementary properties, forming frequently used pairs. For example, the combination of Scutellaria baicalensis and Coptis chinensis can enhance anti-inflammatory and antimicrobial effects [51]. However, there is often a lack of clear scientific data supporting the dose-response relationships of many combinations [52].

2.2.2. Component ADME

In the study of the ADME of Chinese medicine components, traditional radiolabeling techniques are not suitable for tracking complex components of Chinese medicine. Modern mass spectrometry, particularly liquid chromatography-high resolution mass spectrometry, is well-suited for analyzing Chinese medicine components and their metabolites, opening new avenues for studying the ADME characteristics of Chinese medicine [53]. Moreover, facing the complex chemical composition of Chinese medicine and its typical application as combination therapy, researchers have established multi-component PK and drug combination PD methods to assess drug interactions [54].

2.2.3. Dose-response relationship of ingredients

The dose-response relationship of ingredients is a core concept in multiple biological fields such as pharmacology, toxicology, and risk assessment [55]. It describes the relationship between drug dose and biological response, determining not only the appropriate dose and frequency of a drug in populations but also crucial for the development of new cytotoxic drugs [56]. The dose-response relationship is typically characterized by a sigmoidal model [57], ranging in complexity from simple single-parameter equations to complex multi-compartment PK-PD models. For instance, studies on Huashi Baidu decoction (Q-14) have identified bioactive compounds with dose-dependent inhibitory effects on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), highlighting the importance of dose-response research in Chinese medicine [58].

2.3. Function—What: Mechanism of action

“Function” examines the purposes and outcomes of the system, elucidating the clinical efficacy and mechanisms of action of TCM formulations. This involves a detailed examination from macro to micro levels, merging TCM theory with modern biological insights to uncover the therapeutic principles of Chinese medicine.

2.3.1. Efficacy of herbal medicine

Guided by TCM theory, the efficacy level of herbal medicine classifies and summarizes the therapeutic and health-promoting effects of herbs. Herbs are categorized by their expected therapeutic effects, such as “clearing heat” or “invigorating blood to dispel stasis,” providing a clear framework for understanding how ancient physicians chose appropriate herbs based on specific patient syndromes [59]. For instance, some studies classify herb actions into different efficacy categories based on TCM theory, illustrating effective use of heat-clearing and detoxifying herbs in slowing the progression of hand, foot, and mouth disease [60].

2.3.2. Biological mechanisms of components

At the component level, we examine how specific chemical components function within an organism. For instance, flavonoid compounds can activate antioxidant pathways, producing anti-inflammatory effects and inhibiting the activity of inflammation-related enzymes, thereby reducing inflammatory responses [61]. Studies show that flavonoids can modulate the inflammatory response in cardiovascular diseases by inhibiting key pathways and reducing inflammatory cytokine expression [62].

2.3.3. Targets of ingredients

At the level of targets of ingredients, we focus on the binding of single chemical entities to specific receptors within an organism and the mechanisms by which they activate or inhibit related biological responses [63]. Analyzing the interaction networks of TCM ingredients with biological targets reveals at the micro level how TCM produces therapeutic effects. For example, computational analysis of target-disease associations for commonly used Chinese herbs provides strategies for the design of targeted herbal formulations for chronic diseases [64]. Currently, emerging single-cell multi-omics technologies are becoming key tools for identifying and validating targets of ingredients of Chinese medicine [65].

2.4. Boundaries—Which: Clinical positioning

“Boundaries” define the research scope by concentrating on specific system factors and minimizing external disruptions. This concept is crucial for determining the clinical application of Chinese medicine interactions with TCM syndromes, offering a clear research direction and ensuring a systematic, profound analysis.

2.4.1. TCM syndromes

This level concentrates on TCM’s traditional classification and description of diseases and symptoms. For instance, “liver qi stagnation” indicates an impeded flow of liver energy, which can lead to physical and emotional issues. This describes not only clinical symptoms but also involves constitution, lifestyle, and other factors, providing us with a comprehensive understanding of the system’s starting point. In practical applications, TCM therapies have shown promising results in treating cancer-related depression, demonstrating the potential of TCM as an alternative therapy [66]. Similar TCM syndromes under different pathological states indicate that TCM syndrome classification transcends the boundaries of specific diseases [67].

2.4.2. Pathophysiological characteristics

Integrating modern medical viewpoints and technologies, this level enables more accurate identification and description of the biomedical characteristics of TCM syndromes. “Damp-heat” in TCM corresponds to specific inflammatory responses or metabolic abnormalities in modern medicine, forming a bridge between ancient TCM theories and contemporary biomedicine. For example, adipotoxicity, hypoxia, and inflammation in obesity align with the pathophysiological characteristics of the TCM “damp-heat” syndrome [68] and are associated with chronic low-grade systemic inflammation, which are driving factors for metabolic diseases.

2.4.3. Biomarkers

At this level, we focus on biomarkers associated with specific TCM syndromes or disease states. Identifying and distinguishing biomarkers of different TCM syndromes enhances the objectivity of diagnosis and the efficacy of treatment. Multi-omics studies chemically characterize Chinese herbal medicine ingredients and analyze biofluid samples, revealing how these herbs induce dynamic biomarker changes at molecular and cellular levels [69]. Furthermore, utilizing dynamic network biomarker algorithms to analyze transcriptomic data from patients with chronic hepatitis B, clinical validation of biomarkers for heart yin deficiency and heart yang deficiency in chronic heart failure syndrome has underscored the potential for diagnosing critical states in TCM syndromes [70].

2.5. Environment—Where: External conditions

“Environment” considers the external factors that influence the system, such as the patient’s constitution, lifestyle, and socio-psychological conditions. Understanding these external conditions is vital for tailoring treatments to individual needs, thereby optimizing therapeutic outcomes.

2.5.1. TCM constitution

Constitution reflects an individual’s susceptibility to diseases, arising from the interplay between genetics and environment [71]. Research has indicated that certain constitutional types may be more prone to specific diseases such as depression [72]. Analyzing the relationship between TCM constitutional types and diseases lays the foundation for health management and disease prevention [73]. Studies have also explored the connection between the nine types of TCM constitution and conditions such as being overweight, obese, and underweight [74], which aids in offering precise health management plans for individuals.

2.5.2. Epigenetic characteristics

The field of epigenetics highlights the dynamism and modifiability of genetic information, influenced by environmental factors and regulated by epigenetic mechanisms [75]. Core epigenetic regulatory pathways, such as DNA methylation and chromatin remodeling, play a decisive role in the ADME of drugs and are closely related to adverse drug reactions [76]. For instance, drugs and their metabolites can alter epigenetic states, resulting in varied drug responses among patients. The capability of TCM to modulate epigenetic modifications offers new strategies for the prevention and treatment of diseases such as atherosclerosis [77].

2.5.3. Personalized treatment

Personalized treatment accounts for each patient’s unique traits, including genetics, TCM constitution, lifestyle, and disease history, which are crucial for customizing treatment strategies, dosages, and courses [78]. TCM provides personalized treatment recommendations for chronic disease patients based on constitution theory, achieving precise diagnosis and therapy by comprehensively identifying syndromes, diseases, and constitutions [79]. The alignment of traditional TCM constitutional classification with modern genetic typing foresees a shift in medicine from holistic to personalized and refined treatment [80]. The integration of modern biotechnology and advanced diagnostic methods with the TCM typing treatment model paves new paths for the development of personalized TCM treatments and health maintenance.

2.6. Application: TCM research in cancer therapy

Expanding on the foundational systems theory-guided framework established in earlier sections, this analysis extends its disciplined methodology to the domain of cancer therapy, underscoring the significant role of TCM as a valuable adjunctive treatment. Recognized internationally for its prowess in bolstering immunity, stabilizing physiological balance, and actively suppressing the proliferation of cancer cells, TCM’s assimilation into oncological treatment regimens demonstrates its all-encompassing approach to health care [81], [82], [83].

Fig. 5 serves as a visual exposition, employing a structured, top-down methodology to dissect the intricate application of TCM in oncology, encompassing its elements, structure, function, boundaries, and environment interactions. This comprehensive examination includes bioactive component screening, augmentation of therapeutic structures, modulation of biological pathways, stratification of oncological stages, and the development of prophylactic strategies influenced by environmental factors. This detailed case study emphasizes the nuanced integration of TCM throughout the cancer therapy lifecycle—from prevention to treatment and management—providing a blueprint for systematically exploring TCM’s potential in cancer therapy and beyond.

In TCM “elements,” research has identified several Chinese herbs, including Astragalus and its compounds, for their pronounced anti-cancer properties [84], [85]. These components have demonstrated potential in clinical trials, highlighting TCM’s role in advancing anti-cancer drug development through methods like metabolomics and network pharmacology [86]. The “structure” of TCM in cancer therapy emphasizes its crucial role in combination treatments [87]. TCM enhances the efficacy of primary cancer treatments, reduces side effects, and modulates anti-tumor immune responses. Integrating TCM small molecules with conventional drugs demonstrates the potential to enhance cancer treatment outcomes and patient responsiveness [88].

“Function” delves into how TCM formulations influence cancer, revealing their capability to intervene in cancer progression through various biological pathways [89]. These actions include modulating the tumor microenvironment, reversing tumor immune escape, and effectively combating multidrug resistance, highlighting TCM’s unique value in tumor immunotherapy [90]. Investigating TCM theory’s “boundaries” aids in precisely understanding cancer progression, providing insights into disease severity, treatment strategies, and intervention timing [91], [92]. TCM’s holistic approach, complemented by modern technologies, enhances precision in cancer treatment, despite challenges in early diagnosis [93], [94], [95].

Lastly, the “environment” aspect highlights TCM’s comprehensive approach to cancer treatment, emphasizing whole-body regulation and prevention [96], [97]. TCM’s preventive strategies, aligned with personalized treatment trends, offer innovative therapeutic avenues by considering individual susceptibilities and genetic factors [98].

3. “Elements-structure-function” bottom-up exploration of material basis

Transitioning from the top-down systems theory framework previously outlined, this section engages in a meticulous, bottom-up investigation of TCM’s material basis via the “elements-structure-function” model. This methodology resonates with the intrinsic nature of TCM’s material basis, aspiring to systematically decode the active components (“who” is acting), their action mechanisms (“why” they are effective), and the resulting therapeutic outcomes (“what” effects are manifested).

This bottom-up method provides a detailed delineation of TCM elements, crucial for utilizing AI in later stages of quantification and inference. Starting from the molecular sphere and scaling upward, this scrupulous definition process is essential for grasping a multi-layered perspective of the material basis. It establishes the foundation for AI to model intricate connections and predict outcomes in TCM compounds, ultimately refining the research process of TCM’s material basis through systematic AI deployment.

Illustrated in Fig. 6, our approach begins with the isolation and classification of pharmacologically active and regulatory substances within TCM at an elemental level. This initial stage sheds light on their attributes and provenance, priming us for discerning their interplay. Advancing to the structural tier, our analysis deepens the understanding of TCM’s approach in harmonizing these components, disclosing the intricacies of drug interactions and self-organization mechanisms. Such knowledge is pivotal for optimizing ADME traits, enhancing drug delivery, and ensuring precise therapeutic targeting. At the functional tier, the exploration clarifies TCM’s extended regulatory influence in clinical settings, showcasing how TCM constituents orchestrate concerted actions throughout the body. This comprehensive inquiry underscores the scientific rigor and precision needed to define TCM’s material basis and illustrates the seamless integration of ancient wisdom with modern analytical methods, thereby enhancing the understanding and utility of TCM remedies.

3.1. Active substances

Active substances are the cornerstone of TCM, driving its therapeutic effects through interactions within the human body. This segment delves into the varied active substances integral to TCM’s efficacy, encompassing inorganic elements, small molecule ingredients, polysaccharides, peptides, microRNAs (miRNAs), and the emerging role of exosomes.

3.1.1. Inorganic elements

Essential for TCM’s effectiveness and safety, inorganic elements such as calcium, magnesium, and zinc—often derived from mineral medicines—play critical roles in bodily functions [38]. Their regulation is vital for TCM quality control, with advanced techniques such as inductively coupled plasma mass spectrometry (ICP-MS) being used for precise measurement [99], [100].

3.1.2. Small molecule ingredients

Small molecules, including alkaloids and flavonoids, are key to TCM’s pharmacological diversity, offering a range of therapeutic actions from antioxidant to anti-inflammatory effects. Modern analytical technologies, combined with big data and AI, advance the identification and mechanistic study of these molecules [101].

3.1.3. Polysaccharides

Found in various medicinal materials, polysaccharides exhibit immunomodulatory and anti-tumor activities. Their interaction with the gut microbiota, crucial for various physiological functions, underscores the complexity of TCM’s action mechanisms [102], [103]. Given that “structure determines function,” precise identification of polysaccharide structures is crucial. However, due to their highly complex structure, high molecular weight, and branched characteristics, precise identification of polysaccharide structures remains a challenge.

3.1.4. Peptides

Peptides are highly bioactive components in TCM, consisting of multiple amino acids linked by peptide bonds. They are abundantly present in snake venom, bee venom, and certain herbs and have been proven to have significant immunomodulatory, anti-inflammatory, anti-tumor, and antioxidant pharmacological effects [104]. However, peptide research and application face challenges due to their complex molecular structures and sensitivity to environmental factors like temperature, pH, and enzymatic activity, which make them prone to degradation and instability. Additionally, the bioavailability of peptides, especially their oral absorption rates, is generally low, limiting their potential in drug development [105]. Cutting-edge techniques in liquid chromatography-mass spectrometry (LC-MS) and proteomics are crucial for exploring their therapeutic potential [106].

3.1.5. miRNA

miRNAs are short-chain non-coding RNA molecules about 21 to 24 nucleotides in length, primarily regulating gene expression by binding to the 3′ untranslated region of target messenger RNAs (mRNAs), thereby affecting key biological processes such as cell proliferation, differentiation, and apoptosis. The therapeutic potential of miRNAs, still in the early stages of exploration, has shown promise for treating various diseases [107]. TCM research is gradually uncovering the important role of miRNAs in active ingredients. For example, miR2911 found in Lonicerae Japonicae Flos has shown unique stability and can directly inhibit viral replication within the host, accelerating patient recovery [108]. miR162a from goji berries can enter the bloodstream through oral intake and promote osteoblast formation, potentially impacting the treatment of osteoporosis [109]. The miRNAs currently identified in relation to TCM are just the tip of the iceberg, and it is expected that more cases of TCM-miRNA interactions will be discovered in the future, providing new directions and ideas for TCM new drug development.

3.1.6. Exosomes

In cell biology, exosomes generally refer to a subtype of extracellular vehicles (EVs), which are vesicles released by cells into the extracellular space. Although the term “nanoparticles” is also used to describe similar structures in some literature, it refers to a broader category of substances at the micro and nanoscale. As a subset of EVs, exosomes show an increasing value in TCM research. Exosomes, loaded with various RNAs, proteins, and lipids, facilitate key information transfer between cells, influencing and regulating physiological and pathological processes [110]. Studies have found that exosomes extracted from ginseng have the potential to inhibit the growth of melanoma [111] and differentiation of osteoclasts [112]. By deeply analyzing exosome composition, we can more precisely decipher TCM’s mechanisms of action at the cellular and tissue levels. Additionally, exosomes are explored as a novel drug delivery system with potential to enhance drug bioavailability and targeting [113]. Although extracting high-purity exosomes from TCM poses technical challenges, there is reason to anticipate a more comprehensive understanding of exosomes’ unique role in TCM in the future.

3.2. Biopharmaceutical regulatory substances

In TCM, alongside active substances that directly contribute to therapeutic outcomes, a range of biopharmaceutical regulatory substances also plays a crucial role. These substances play a crucial role in the PK of TCM formulations, significantly influencing the ADME of active ingredients. Furthermore, they serve to modulate toxicity and bolster both the efficacy and safety of TCM treatments. The origins of these regulatory substances are diverse, spanning from excipients and the TCM ingredients themselves to various biological environmental factors.

3.2.1. Excipients

Introduced during TCM processing, excipients like alcohol, vinegar, salt, and honey stabilize drug effects and actively regulate physiological targets and drug transport mechanisms, such as P-glycoprotein transport [114], [115]. For example, cyclodextrins are notable for enhancing drug solubility and engaging in biological interactions relevant to cholesterol management and Alzheimer’s disease therapy [116].

3.2.2. TCM itself

Within TCM’s complex formulations, certain ingredients embody the concept of “medicine-auxiliary unity,” acting simultaneously as active agents and regulatory elements. Flavonoids not only offer anti-inflammatory or antioxidant benefits but also modulate the activity of metabolic enzymes and transport proteins, thereby affecting the PK of co-administered substances [117]. Polysaccharides exemplify another dual role; they provide immunomodulatory effects and improve the solubility and stability of other active compounds, thus enhancing overall therapeutic action [118].

3.2.3. Biological environmental factors

The interaction of TCM components with endogenous substances, such as bile salts and plasma proteins, significantly influences drug behavior. Bile salts facilitate lipid digestion and absorption and, in conjunction with specific transporters and other molecules, can enhance drug bioavailability [119], [120]. Additionally, the binding of drugs to plasma proteins upon entering the bloodstream profoundly impacts drug distribution and efficacy, with variations in internal factors like pH and electrolytes further contributing to differences in drug action among individuals [121].

3.3. Drug combinations

In both modern medicine and TCM, drug combinations are strategic in enhancing treatment efficacy, reducing toxicity, and preventing resistance, especially for complex conditions such as cancer and infectious diseases. The combination theory in TCM is crucial for analyzing interactions within multi-component formulations. It examines the independent action of each component as well as the synergistic or antagonistic effects arising from their interactions. This dual perspective is vital for appreciating the complex interplay of components in TCM and for designing effective combination therapies.

3.3.1. Independent drug actions

Independent drug action is a principle of drug combination where each drug exerts its pharmacological activity independently, without interaction or influence from others [122]. This means that the effect of each drug in the combination does not depend on the presence of other drugs. The main advantage of independent drug action is that it provides multiple opportunities for patients with varying drug sensitivities to benefit from at least one drug, potentially increasing treatment effectiveness and success rates. This is particularly evident in TCM, where different components may target different physiological pathways or pathological processes, providing multiple therapeutic entry points for different patient groups. This multi-targeted efficacy is a distinct advantage of TCM.

3.3.2. Combined drug effects

In contrast to independent drug actions, combined drug effects emphasize the mechanisms and outcomes of drug interactions [123]. Components in TCM often interact, producing synergistic or antagonistic effects, and such interactions can help enhance efficacy or reduce side effects. For example, the combination of Shuanghuanglian formulation with antibiotics can significantly enhance therapeutic effects [124]. Under synergistic action, the combined effect of two drugs, like stevioside and eugenol interacting on specific biological pathways, exceeds the sum of their individual effects, offering cardiac protection [125]. In antagonistic action, one drug may reduce the effect of another, such as the interaction between TTA-A2 and paclitaxel at the same active site [126]. Potentiation occurs when one drug, such as lycopodium acid, enhances the effect of another—like the antimicrobial activity of antibiotics—even if it has no significant effect alone [127]. These modes of action are not only crucial for understanding the efficacy of TCM but also provide new perspectives for drug design.

3.3.3. Evaluating combined drug effects

Methodologies for evaluating combined drug effects have significantly evolved, integrating advanced computational techniques with traditional pharmacological approaches. Notably, advancements have focused on utilizing both effect-based and dose-effect-based methods for a comprehensive assessment of drug combinations [128]. Zheng et al. [129] introduce SynergyFinder Plus, enhancing the analytical landscape with extended mathematical models that facilitate nuanced analyses of drug synergy and sensitivity. This platform integrates statistical evaluations and confidence intervals, providing a deeper understanding of combination therapies. In parallel, Malyutina et al. [130] present a cross design with sensitivity and synergy scoring, streamlining the evaluation of drug interactions. This approach is noted for its reproducibility and efficiency, reducing the reliance on extensive experimental materials. Together, these innovations mark a transition to a more holistic analysis, merging mathematical rigor with pharmacological insights to refine the process of selecting and evaluating drug combinations.

3.3.4. Predicting combined drug effects

In the pursuit of identifying synergistic drug combinations, research strategies increasingly incorporate computational methods to navigate the extensive datasets associated with drug pairing and dosage combinations [131]. These methods utilize public genomic and phenotypic resources to offer insights into cellular responses to drugs and aid in developing algorithms that predict effective drug combinations [132]. Furthermore, analyzing the interplay between drug targets and disease-associated proteins within protein interaction networks illuminates the potential of diverse drug-drug-disease combinations, paving the way for novel therapeutic strategies [133].

Recent advancements exemplify this shift towards computational synergy prediction. Malyutina et al. [130] introduced a novel cross design paired with a drug combination sensitivity score and an S synergy score. This approach optimizes the evaluation of drug interactions, ensuring robust and precise assessments with reduced experimental requirements, thus enhancing the discovery rate in high-throughput drug combination screenings. Complementing this, Gan et al. [134] applied a network medicine framework to TCM, demonstrating that the network proximity of an herb’s targets to symptom-related modules within the human protein interactome can predict the herb’s effectiveness in treating specific symptoms. This method not only validates the scientific basis of TCM but also sets a precedent for the molecular understanding of natural medicine. Together, these studies underscore the indispensable role of computational tools in the modern landscape of drug combination research, enabling a more efficient and scientifically grounded exploration of therapeutic potentials.

3.4. Self-assembly

Self-assembly, where molecules naturally organize into stable, ordered structures, is increasingly recognized in TCM research for its pharmacological and pharmaceutical implications. This process, central to nanotechnology due to its environmental friendliness, biodegradability, and biocompatibility, has become instrumental in the development of novel drug delivery systems [135], [136]. For example, traditional TCM decoction techniques can induce self-assembly of herbal compounds into nanoparticles, enhancing the bioavailability of medicines [137], [138]. Additionally, interactions between TCM compounds and the body’s endogenous molecules like bile salts or proteins can modify the efficacy and distribution of drugs [139].

Technological advances have opened new avenues for exploring self-assembly in TCM, leading to the creation of targeted drug delivery mechanisms, particularly for cancer treatment. These mechanisms utilize biomimetic approaches for enhanced specificity in tumor targeting, offering promising prospects in therapy and diagnostics [140], [141], [142], [143]. The discussion on self-assembly in TCM spans several areas, including the behavior of small and large molecules and their interactions with endogenous small molecules and macromolecules. This comprehensive approach sheds light on the varied potential of self-assembly for drug delivery within TCM.

3.4.1. Small molecules in TCM

Small molecules in TCM enter nanotechnology through two primary self-assembly mechanisms. One mechanism is the self-assembly of molecules like terpenoids (including betulin, betulinic acid, and oleanolic acid) [144] and steroids and glycosides that form gel-like structures [145], offering significant drug delivery advantages. Moreover, compounds like ursolic acid [146] and rhein [147] have been found to self-assemble into nanostructures to enable effective drug delivery. The second type is the supramolecular assembly of two small molecules, such as berberine and baicalin [148], enhancing biocompatibility and significantly improving antibacterial activity. Additionally, the self-assembly strategy of berberine helps to neutralize the toxicity of aristolochic acid [149]. Similarly, based on like mechanisms, the combination of sanguinarine and baicalin can form hydrogels that enhance antibacterial effects [150].

3.4.2. Large molecules in TCM

In the case of large TCM molecules, self-assembly capabilities allow polysaccharides and proteins to form supramolecular structures with unique functions, affecting the release and absorption of drugs and providing a new direction for controlled release formulations [151]. Polysaccharides can self-assemble in response to pH changes or interact with metal ions [152]. Similarly, the formation of higher-order protein structures, like ferritin [153] and silk proteins [154], is a self-assembly process. The self-assembly capabilities of zein [155] and edible dock proteins [156] in drug delivery are notable, and saponin-involved protein self-assembly can alter material properties [157], opening new research directions for drug delivery technologies.

3.4.3. TCM with endogenous small molecules

The self-assembly of TCM with endogenous molecules like bile acids and phospholipids affects drug behavior in the body. They form supramolecular structures like micelles, enhancing drug absorption and bioavailability. Bile acids, especially in the intestines, interact with drugs to promote drug release [158]. Studies on drug interactions with bile acids have explored their synergistic effects, stoichiometry, and binding constants to understand their interaction mechanisms [159]. Furthermore, stearic acid has been found to enhance the stability of drug salt nanomicelles, promoting gastrointestinal absorption of drugs [160].

3.4.4. TCM with endogenous macromolecules

The interaction between TCM and endogenous macromolecules is critical for the stability, release, and absorption of drugs. Drugs may undergo supramolecular self-assembly with proteins in the digestive system, such as trypsin and pepsin, affecting their catalytic activity. The binding of anthocyanin B3 to trypsin and pepsin [161], the direct inhibition of naringin on these enzymes [162], and the non-covalent interactions of polyphenolic compounds with digestive enzymes [163] are examples of this process. Once in the bloodstream, TCM components may also self-assemble with proteins like albumin and globulin, affecting drug distribution and stability in the blood. Studies show that drug binding to plasma proteins has profound effects on their PK and PD [164]. Hydrophobic interactions and hydrogen bonding enable flavonoid compounds to bind to plasma proteins, affecting their bioavailability [165]. For instance, the low concentration of berberine in plasma and its high concentration in tissues may be related to its self-assembly with hemoglobin [166].

3.5. Remote control

Remote control within the context of TCM refers to the complex interplay among various organs and systems within the body, unveiling new vistas for understanding the multifaceted actions and liver toxicity mechanisms inherent in TCM formulations (Fig. 7). This concept, exemplified in the brain-gut and gut-brain axes, highlights the significance of bidirectional communication pathways in assessing TCM’s efficacy and safety. With advancements in metagenomics and metabolomics, researchers are now better equipped to explore TCM’s influence on gut microbiota and internal metabolites, paving the way for more precise and safe treatment methodologies.

Brain-gut axis: This axis underscores the symbiotic relationship between cognitive states and gastrointestinal health, spotlighting gut microbiota’s role in modulating neurological functions through metabolic byproducts like neurotransmitters and short-chain fatty acids [167]. Such insights are pivotal for tailoring TCM approaches to central nervous system disorders, emphasizing the gut’s influence on mental well-being.

Brain-heart axis: Delving into the interconnection between emotional health and cardiac function, this axis reveals the dual impact of psychological states and heart diseases on each other [168], [169]. It underscores the potential of TCM in harmonizing heart and brain health, offering novel perspectives on treating cardiovascular and neurological conditions.

Brain-skin axis: This pathway illustrates how psychological stressors can precipitate skin disorders through neuroendocrine and immune responses [170], [171]. It advocates for a holistic TCM treatment strategy that addresses both the psychosomatic and physiological aspects of dermatological conditions.

Lung-gut axis: Highlighting the reciprocal influence of respiratory and gastrointestinal health, this axis points to the role of gut microbiota in respiratory diseases [172], [173]. It underscores the importance of maintaining gut health in TCM respiratory treatments.

Liver-gut axis: Focusing on the symbiotic relationship between the liver and the gut, this axis is crucial for understanding the metabolism and potential toxicity of TCM compounds [174]. It emphasizes the role of bile acids in coordinating liver health, vital for TCM treatments targeting liver diseases.

Gut-muscle, gut-bone, and gut-kidney axes: These axes explore the impact of gut microbiota on muscle, bone, and kidney health, respectively, highlighting the extensive influence of the gut microbiota beyond the gastrointestinal tract [175], [176], [177], [178], [179], [180]. They provide a foundation for TCM strategies aimed at preserving muscle mass, enhancing bone metabolism, and managing chronic kidney diseases.

Kidney-bone axis and indirect hepatotoxicity: Examining how renal health impacts bone metabolism [181], [182] and exploring indirect hepatotoxicity mechanisms [183], [184], [185], [186] expand the scope of TCM research to include preventative and treatment strategies for liver injuries.

Through the remote-control networks, TCM research delves into the body’s complex internal networks, enhancing our comprehension of TCM’s therapeutic capabilities and its interactions with various bodily systems. This multidisciplinary approach enriches our understanding of TCM’s mechanisms and paves the way for innovative therapeutic interventions, combining ancient wisdom with modern science.

4. Component as fundamental units of “elements” in material basis

TCM research now emphasizes “components” as fundamental units, marking a paradigm shift towards an integrative understanding of its holistic material basis. This shift from analyzing isolated compounds to exploring synergistic interactions highlights TCM’s complexity and aligns with the dynamic nature of contemporary medical research. Illustrated in Fig. 8, this shift portrays the TCM material basis as a vibrant ecosystem of bioactive substances, emphasizing the collective efficacy of constituents such as alkaloids, peptides, and polysaccharides.

4.1. Definition of TCM components

In addressing “components” within TCM research, it becomes clear that broad categorizations such as “total flavonoids” or “total saponins” barely scratch the surface of their complex nature. To refine our understanding, “components” are explored from compound production, efficacy, and notably, a structure-oriented perspective, which resonates with AI’s analytical capabilities. This approach not only aligns with AI’s prowess in data structuring but also propels AI into the elemental analysis phase, enriching our initial insights. The introduction of “component structure” theory underscores our methodological foundation, promoting a deeper, integrated exploration of TCM’s holistic material basis and bridging traditional wisdom with scientific rigor.

Defining TCM components involves a multidimensional framework that reflects the complexity of TCM and its integration with modern science. These components are essential for determining the efficacy, safety, and quality control of TCM formulations. By employing production-, efficacy-, and structure-oriented perspectives, we gain a thorough understanding of TCM components, enriching their characterization for modern medical use, as depicted in Fig. 9.

4.1.1. Production-oriented

This production-oriented viewpoint links component identification to chemical methods for separation and purification. This approach, exemplified by the development of China’s first natural hypoglycemic drug from mulberry twig alkaloids [187], underscores the importance of processing techniques. Evolving chromatographic methods now aim to achieve extracts with structural component purities exceeding 85% [188], [189]. While offering operational ease and facilitating rapid bioactive molecule utilization, this method calls for further pharmacological studies to explore the holistic efficacy of compound TCM formulations.

4.1.2. Efficacy-oriented

This efficacy-oriented perspective focuses on identifying compounds that reflect TCM’s holistic therapeutic effects. It addresses the complexity within TCM formulations, where multiple active ingredients contribute to therapeutic effects across different targets. This approach is crucial for leveraging TCM’s multifaceted therapeutic potential. For instance, researches from Zhang et al. [190] and Xing et al. [191] at China Pharmaceutical University focus on identifying “combinatorial bioactive ingredients” to replicate the therapeutic effects of original TCM prescriptions. Though complex, this strategy is pivotal in elucidating TCM’s holistic therapeutic effects.

4.1.3. Structure-oriented

Concentrating on molecular structures and their similarities, this approach facilitates the identification of bioactive entities within TCM. Using advanced tools such as ClassyFire [192], Scaffold Hunter [193], and SCONP [194] enhances the efficiency of structural classification and prediction of biological activity in TCM compounds. This structure-oriented approach predicts PK and pharmacological actions of TCM ingredients [195], [196] and leverages AI to transform TCM research, facilitating the rapid discovery of effective components.

4.2. Component structure theory

“Component structure theory” marks a significant advancement in TCM research by focusing on “components” as fundamental units defined by their structural and functional congruence. This theory emerges in response to the need for a deeper, integrated analysis of TCM’s holistic material basis, transitioning from examining isolated bioactive entities to understanding their synergistic interactions. Anchored by three pivotal elements—chemical structure, stoichiometric structure, and aggregate structure—as depicted in Fig. 10, this theory provides a robust framework to address critical challenges in TCM research. These challenges include identifying effective components, determining their optimal dosages, and examining their aggregation states within the body.

4.2.1. Chemical structure

This aspect emphasizes the importance of chemical similarities in classifying TCM components, facilitating a streamlined approach to analyzing TCM’s complex ingredient matrix. By identifying compounds with shared functional groups and potential bioactivity, this method pinpoints pharmacologically active units within TCM formulations. While structural resemblance lays the groundwork, the real challenge lies in correlating these similarities with the compounds’ behavior in a biological context, necessitating an integrated chemoinformatics and bioinformatics strategy to fully anticipate these properties.

4.2.2. Stoichiometric structure

Stoichiometric relationships are central to TCM material basis analysis, focusing on the holistic consideration of components within and among themselves. Initially, the interaction of constituents within a component is examined, assuming independent pharmacological effects due to their structural and biopharmaceutical congruence. The analysis then expands to inter-component relationships, where the cumulative efficacy and possible synergistic or antagonistic effects of combining diverse components are explored. This stoichiometric insight is pivotal for formulating TCM doses and maintaining consistency across different formulations, highlighting the importance of dosage optimization in TCM efficacy.

4.2.3. Aggregate structure

Research delves into the self-assembly behaviors of components and their resulting aggregate structures during formulation and within the body. This examination of both small molecule and large molecule self-assembly, and their interaction with bodily substances like bile salts and proteins, uncovers the influence of these higher-order structures on drug PK. Understanding these molecular assembly mechanisms is crucial for drug design, as it enhances the solubility, bioavailability, and stability of therapeutic agents, ensuring rigorous quality control in TCM formulations.

5. AI in quantification and inference of material basis

In the prior sections of our research, we have meticulously defined the elemental components within the rich tapestry of TCM’s material basis, guided by the comprehensive SFDM. As we pivot from these foundational definitions, we embark on an examination of the current state of AI applications in the intricate process of quantifying and inferring TCM’s material basis.

5.1. Overview of AI technologies

Before delving into the applications of AI in quantifying and inferring the material basis of TCM, it is imperative to comprehend the evolution of AI technologies and their applications in herbal and pharmaceutical development. AI has become a critical factor in enhancing the accuracy and reliability of TCM diagnosis, driving the objective, quantifiable, and standardized evolution of TCM diagnosis towards evidence-based medicine [197]. Moreover, the prospects of AI application in the traditional medical field are broad, particularly in TCM’s four diagnostic methods [198]. AI’s application in TCM, particularly in four key technological directions, shows significant potential.

5.1.1. Machine learning

ML, a core branch of AI, has shown vast potential in the TCM domain. This technology enables effective predictions by learning from massive data sets, crucial for managing complex data in TCM. The application of ML in TCM diagnostics is increasingly widespread. Tian et al. [199] reviewed ML applications in TCM diagnostics, highlighting the importance of data preprocessing, model selection, and evaluation metrics. Furthermore, research by Wang et al. [200] analyzed the molecular features of Chinese herbal medicines and their active components through ML methods, successfully predicting the classification of meridians, demonstrating the potential of ML in enhancing the accuracy of TCM classification.

5.1.2. Natural language processing

NLP is a technology that allows computers to understand, interpret, and generate human language, crucial for in-depth analysis of medical literature and precise processing of patient records. With the introduction of transformer architecture and its derivatives like bidirectional encoder representations from transformers (BERTs) and generative pre-trained transformer-4 (GPT-4), pre-trained on extensive text data, NLP has undergone revolutionary progress, significantly enhancing machine translation and text comprehension capabilities. The rapid development of large language models is reshaping research across fields, offering a novel approach to the complex domain of molecular studies [201].

For instance, a study utilized the BERT model to construct a standardized model for TCM symptoms, effectively unifying various expressions of synonymous TCM symptoms, greatly improving data processing accuracy and efficiency [202]. Furthermore, NLP technologies extend beyond text analysis to the development of auxiliary diagnostic systems. Another study developed an AI-based TCM auxiliary diagnostic system capable of processing unstructured notes in electronic health records using bidirectional long short-term memory networks-conditional random forests (Bi-LSTM-CRF) and convolutional neural networks (CNNs), accurately diagnosing various common diseases and generating corresponding syndrome lists [203].

5.1.3. Computer vision

The application of computer vision technology in the TCM domain, especially in medical image analysis, has proven its indispensable value. This technology, which processes information from digital images or videos, is becoming integral to TCM diagnosis and treatment. A key research area is tongue image analysis, using deep learning to diagnose stomach cancer by examining tongue images and their microbiome, verifying the practicality of computer vision in traditional TCM tongue diagnosis and showcasing its huge potential in enhancing disease diagnosis accuracy [204]. Additionally, hyperspectral imaging technology combined with ML has been effectively applied in quality control of Chinese medicines. By conducting in-depth analysis of hyperspectral data of Chinese medicines, this technology has significantly improved the accuracy and efficiency of Chinese medicine quality assessment, providing strong technical support for the standardization and quality supervision of Chinese medicine preparations [205].

5.1.4. Knowledge representation and reasoning

Knowledge representation and reasoning in TCM focuses on effectively expressing and processing TCM knowledge in computer systems to support decision-making and new drug discovery. This involves creating knowledge graphs with extensive medical concepts and relationships, enabling AI to perform complex reasoning and support medical decision-making. This process not only facilitates a deeper understanding of TCM knowledge but also provides researchers with a powerful tool for discovering new treatment methods and drugs [206].

In specific application cases, several studies have demonstrated the practical utility of knowledge representation and reasoning technologies in the TCM domain. For example, Li et al. [207] developed a recurrent neural network model using a TCM cerebral palsy knowledge graph and electronic medical records to enhance diagnostic accuracy. Zhao et al. [208] constructed a TCM knowledge graph applied to the potential knowledge discovery of diabetic nephropathy, systematically mining and sharing diagnostic and treatment knowledge to enhance the information support for medical decision-making. Additionally, Jin et al. [209] proposed knowledge graph-enhanced multi-graph neural network (GNN) model for herbal recommendation showcases how to utilize attention mechanisms and TCM knowledge graphs to improve the precision and quality of herbal recommendation systems.

5.1.5. Application of AI in the study of TCM material basis

Table 1 [210], [211], [212], [213], [214], [215], [216], [217], [218], [219], [220], [221], [222], [223], [224], [225], [226], [227], [228], [229], [230], [231] summarizes a series of representative research cases, showcasing the application of AI technologies, such as deep learning and ML, in the study of the material basis of TCM. These studies leverage AI technologies to enhance the precision in analyzing TCM components and deepen the research on pharmacological mechanisms. By processing and analyzing vast amounts of data, AI not only accelerates the screening process for new TCM components but also enhances the personalization and accuracy of drug research and development. These technologies not only modernize TCM research but also bolster scientific support for its safety and efficacy.

5.2. AI in quantitative analysis

Quantitative analysis in TCM research aims to systematically identify and evaluate the physicochemical properties, chemical composition, and biopharmaceutical behaviors of TCM components, laying the foundation for in-depth mechanistic studies and clinical applications. Traditional analysis methods are limited by inefficiency, subjectivity, and lack of automation. The introduction of AI technologies can overcome these barriers, propelling rapid advancement in the modernization of TCM research.

5.2.1. Identification of medicinal material sources

In TCM research and practice, ensuring the authenticity and high quality of medicinal materials is crucial. Combined with DNA barcoding techniques, AI offers a revolutionary method for identifying medicinal material sources. This approach, by analyzing genetic information, can precisely identify and differentiate types of medicinal materials, significantly enhancing the accuracy of identification [232]. AI-assisted image recognition also excels in efficiently and accurately identifying the morphology of medicinal materials, quickly verifying their authenticity and quality, playing a vital role in source tracing and quality control [233].

5.2.2. Identification and classification of chemical components

The complex chemical components of TCM are the material basis of its therapeutic effects, and AI technology shows immense potential in the identification and classification of these components. AI accelerates the identification and precise classification of chemical components in complex TCM through high-throughput screening and automated analysis [234]. Using advanced technologies like GNNs, AI can predict compound properties directly from molecular structures without traditional molecular descriptors, significantly improving the efficiency and accuracy of chemical analyses [235].

5.2.3. Analysis of biopharmaceutical properties

The biopharmaceutical properties, including the ADME characteristics of drugs, are crucial for evaluating drug bioavailability and safety. The application of AI technology in this field, through molecular simulation and intelligent prediction, enables efficient and precise assessment of physicochemical parameters and ADME characteristics. GNNs excel at predicting complex molecular properties, handling multifidelity datasets, and applying transfer learning [236]. Moreover, the use of physiologically-based PK (PB-PK) models allows for the simulation of drug distribution processes in various tissues and organs within the body, providing accurate predictive information for new drug development and safety evaluation [237].

5.3. AI in inference analysis

The inference analysis phase of TCM material basis research requires in-depth exploration of the mechanisms of action, interaction networks, individual variations, and potential indications of active TCM components, crucial for the modernization and clinical translational application of TCM. AI’s capabilities in multidimensional data mining and knowledge discovery are reshaping traditional reasoning modes fundamentally, injecting new momentum into uncovering the unique molecular regulatory principles of TCM and expanding its clinical application scope.

5.3.1. Efficacious substances and mechanisms of action

AI, combined with computational omics technologies, displays great potential in identifying efficacious substances and deducing mechanisms of action. AI algorithms can efficiently identify molecules with potential therapeutic effects from vast databases of natural products, accelerating the new drug discovery process [238]. This involves constructing computational models to accurately predict interactions between molecules and target proteins, delving into their molecular mechanisms of action [239]. For instance, through structure-activity relationship (SAR) models and AI algorithms, researchers can quickly identify TCM components with specific pharmacological activities, such as hepatoprotective effects [214]. Additionally, using quantitative SAR (QSAR) models to predict potential toxicity of compounds provides a scientific basis for pharmacotoxicological evaluations, further ensuring drug safety [231].

5.3.2. Interactions from a systems biology perspective

The holistic efficacy of TCM derives from the interactive effects of active molecules within its complex component system. The application of network pharmacology, coupled with AI technologies, enables the dissection of the complex interactions between TCM components and biological networks from multi-omics data [240]. AI-enhanced network medicine frameworks systematically map disease symptoms and TCM targets onto the human protein interaction network, revealing the molecular underpinnings of TCM’s diagnostic and therapeutic principles [134]. This approach not only facilitates a deeper understanding of TCM’s scientific basis but also, by delineating the interaction patterns between disease and drug molecular networks, sheds light on the molecular origins of diseases and identifies crucial treatment interventions. Furthermore, AI technologies can extract patterns of patient symptoms and drug response modes from extensive clinical datasets, providing vital decision support for the customization of treatment plans and dosage optimization [241].

5.3.3. Discovery of new indications and therapeutic potentials

AI technology, particularly virtual screening and molecular docking, efficiently uncovers active molecules with therapeutic potential from TCM resources. Computational similarity analyses, assessing the similarity between TCM molecules and known drugs, can predict new indications for TCM molecules, offering strong clues for the development of new therapeutic targets [242]. Furthermore, large-scale virtual screening methods can identify a variety of potential active compounds from TCM that may be effective against osteoporosis [243], antiviral activities (e.g., against SARS-CoV-2) [213], and more, greatly expanding the application potential of TCM in the treatment of these diseases.

6. Advanced AI applications in TCM material basis research

Building on foundational research, this study introduces two advanced AI-driven proposals to enhance the bottom-up analysis of TCM’s material basis. These proposals aim to harness AI’s full potential in navigating the complex, multi-dimensional interactions that characterize TCM formulations, offering innovative solutions to longstanding research challenges.

6.1. “Component-syndrome” end-to-end data-driven model

Building on previous discussions, the “component-syndrome” end-to-end data-driven model, as depicted in Fig. 11, represents a significant advancement in TCM research. This model leverages AI to decode the complex relationships among TCM components, biological targets, and clinical syndromes. Its development signifies a pivotal shift from analyzing individual components to embracing a holistic, multi-component framework, acknowledging that the efficacy of TCM stems from the dynamic interplay of multiple components.

The rationale behind this model stems from the limitations of existing AI models, such as QSAR and molecular docking, which focus on isolated interactions between components and biological targets. These models, while insightful, do not encompass the entirety of TCM’s intricate approach, which often involves a symphony of components acting in concert across multiple pathways to address a range of syndromes. The “component-syndrome” model extends beyond the scope of component-target models by encapsulating the synergy between multiple components and their collective impact on a spectrum of clinical syndromes. Where component-target models map a single pathway, the “component-syndrome” model leverages a network approach, acknowledging that the therapeutic impact of TCM extends across a network of biological pathways.

6.1.1. Core principles

We base the “component-syndrome” model on the principle of molecular similarity, positing that structurally similar molecules exhibit similar biological activities. Given that TCM formulations contain a variety of chemical components, their interactions and synergistic effects are crucial for the overall therapeutic effectiveness. We start by constructing a “component-component” topological network, grouping chemically similar components, and then expand to a “component-target-syndrome” network analysis, exploring how each chemical component interacts with specific biological targets and affects clinical syndromes. Ultimately, we develop the “component-syndrome” end-to-end model, moving beyond the analysis of single chemical components and focusing on how components are associated with specific clinical syndromes. This reveals at a macroscopic level how TCM components collectively act on biological pathways and influence syndromes.

6.1.2. Main algorithms

GNNs are central to constructing the “component-syndrome” model, ideal for managing complex network structures in TCM research. GNNs effectively capture the complex relationships between chemical component nodes and their interactions within the network. For instance, Lee et al. [244] demonstrated the application of GNNs in establishing mapping relationships between molecular structures and specific attributes, such as odor. Similarly, Gautam et al. [245] utilized GNNs in their QSAR model to predict the blood-brain barrier permeability of metabolites produced by humans and microbiomes. These case studies highlight the strong potential of GNNs in deciphering complex chemical data and predicting compound properties, further proving their value in constructing “component-component” and “component-syndrome” networks. Therefore, GNNs are an ideal tool to help deepen our understanding of the complexity and holistic effectiveness of TCM.

6.1.3. Technical steps

(1) High-throughput screening and identification: Using techniques like LC-MS to obtain detailed spectral data is crucial for identifying various chemical components. Molecular network topology and structural similarity fingerprinting are used for pattern recognition and component identification in the obtained spectral data [246], aiding in accurately identifying key chemical components from complex data.

(2) Data-driven component clustering: Utilize cheminformatics and GNNs to cluster identified chemical components based on molecular similarity. The key here is using GNNs to decipher complex interactions between molecules and cluster components based on these interactions. Each component represents a group of chemically similar components, laying the foundation for subsequent network analysis.

(3) Component interaction and activity prediction: Use a “component-target-syndrome” network to link TCM syndromes [134], and use GNNs to predict component interactions and pharmacological activities. Combining known pharmacological data and biomarker information, the “component-syndrome” end-to-end data-driven model can predict the potential therapeutic activity of each component, furthering our understanding of how they collectively act on specific biological pathways and clinical syndromes.

6.2. Oral formulations IVIVC mechanistic model

A key challenge in bottom-up analysis of TCM is accurately predicting and understanding the complex mechanisms of oral TCM formulations within the human body. The multi-component nature of TCM results in nonlinear and multidimensional complexities in their therapeutic effects, with traditional research methods often failing to capture the dynamic interactions among various components and their comprehensive interaction with biological systems. Therefore, we propose the application of AI technology, particularly mechanistic models, to overcome these challenges.

As shown in the Fig. 12, AI mechanistic models are applied here to optimize IVIVC studies for oral TCM formulations. This includes simulating processes like drug dilution and ADME, which often overlap and interact spatially, surpassing simple independent or linear relationships. Especially for multi-component systems like TCM, considering factors like molecular structure, self-assembly, macroscopic movement within the gastrointestinal tract, PK, and interactions between organ systems necessitates an advanced model that can integrate all these aspects.

Using AI to construct and optimize these mechanistic models deepens our understanding of TCM component behavior and their interactions with complex biological pathways in the human body. This understanding is vital for predicting clinical effects, designing appropriate dosages, and minimizing adverse reactions. Therefore, optimizing IVIVC studies with AI not only enhances the accuracy of efficacy assessment and safety evaluation of TCM but also provides scientific support for the modernization and international development of TCM. The following sections will provide a complete research guidance plan for optimizing the mechanistic model of oral drug IVIVC, covering core principles, main algorithms, and technical steps.

6.2.1. Core principles

A major challenge is combining dissolution and absorption models to simulate the ongoing dynamic behavior of oral drugs in the gastrointestinal tract [247]. Therefore, we propose an IVIVC optimization method for oral drugs, centering on the application of the PB-PK model. This model, based on a deep understanding of biology, predicts drug behavior in the human body, especially in the context of oral administration, and has shown great potential in new drug development [248]. The application of the PB-PK model is particularly important for multi-component systems like TCM. The complexity of TCM arises not only from its diverse chemical components but also from their intricate interactions within the body. The PB-PK model allows us to consider the molecular structure of drugs, their self-assembly characteristics, macroscopic movement in the gastrointestinal tract, PK properties, and interactions between different organ systems. This comprehensive model helps us more accurately predict drug behavior in the body, especially for complex TCM formulations.

6.2.2. Main algorithms

Molecular dynamics simulation: This computational method simulates the behavior of molecular systems over time. It simulates the trajectories of molecules over time by calculating the forces and movements of particles interacting with each other. In IVIVC studies, molecular dynamics simulation can predict the behavior of drug molecules in specific environments in the body, such as the dissolution and absorption processes in the gastrointestinal tract. This simulation helps understand how the molecular structure of drugs affects their bioavailability and PK properties, particularly when considering complex multi-component systems of TCM.

Bayesian algorithms: These statistical methods update the probability of hypotheses or parameters using prior knowledge and new data. In IVIVC models, Bayesian algorithms can be used to optimize model parameters, especially in situations with scarce data or high uncertainty. By combining prior knowledge (such as known drug properties) and new experimental data, model parameters can be estimated more accurately. Bayesian methods also allow for the quantification of uncertainty, providing confidence intervals for model predictions, which is especially useful for clinical decision-making.

Combining these two algorithms, molecular dynamics simulation provides a microscopic view of drug behavior, while Bayesian algorithms help optimize and validate the model’s predictive capabilities at a macroscopic level. This multi-faceted approach not only enhances understanding of drug behavior but is particularly important in addressing the challenges of complex multi-component systems in TCM. This integrated approach allows for a more comprehensive assessment of the IVIVC properties of drugs, providing stronger scientific support for the effectiveness and safety of TCM oral formulations.

6.2.3. Technical steps

(1) Dynamic dissolution-absorption simulation: This employs molecular dynamics simulation to predict how oral drugs dissolve and absorb in the gastrointestinal tract. This simulation considers the complex physiological variable interactions during the drug dissolution process, such as fluctuations in pH, enzyme activity, and concentrations of bile salts and phospholipids. For instance, our previous research elucidated the mechanism of action of bile salts and phospholipids on the permeability enhancement of discontinuous saponin components in the gastrointestinal environment, improving the understanding of drug absorption mechanisms [249].

(2) Multi-scale model integration: This approach integrates various scale models to capture the behavior of multi-component TCM mixtures in the body. This includes everything from the self-assembly details of drug molecules to their macroscopic movement in the gastrointestinal tract. For example, our prior research indicated that Astragalus polysaccharides could improve the biopharmaceutical properties of saponin components [250]. The application of multi-scale models not only reveals the self-assembly process of drug molecules but also simulates their movement in the gastrointestinal tract, key to understanding how TCM forms aggregates and nanostructures in the gastrointestinal tract, thus optimizing drug release curves and guiding clinical dosage design.

(3) PB-PK model optimization: These enhance predictive accuracy using Bayesian networks and other ML techniques. These methods allow for a comprehensive simulation of drug ADME, considering spatial interactions and overlaps between these processes [251]. These advanced techniques can integrate data from different laboratories and clinical trials, automatically adjusting model parameters, improving the model’s applicability in different populations. The application of Bayesian networks, especially in handling drug molecular structure, macroscopic movement in the gastrointestinal tract, PK properties, and interactions between organ systems, offers deep insights.

7. Conclusions

This study establishes a robust methodological framework that integrates AI with TCM through the SFDM, aligning with the complexity of TCM and the analytical precision of AI. It begins by elucidating the complexities of TCM’s holistic material basis and systematically unveils TCM’s research framework using a systems theory-guided top-down approach. The narrative highlights TCM’s holistic nature and demonstrates AI’s transformative impact in decoding the complex interrelations within TCM formulations. This includes a detailed analysis of active substances, biopharmaceutical regulatory substances, drug combinations, and self-assembly mechanisms explored from a bottom-up perspective. We emphasize the importance of viewing “components”—groups of structurally and functionally similar constituents—as fundamental units to articulate the entirety of TCM material basis. The introduction of the “component structure theory” addresses key aspects to consider during research, such as chemical structure, stoichiometric relationships, and aggregate states of components.

Moreover, AI technologies like ML, NLP, and computer vision are pivotal in advancing the research on TCM’s material basis. In the realm of quantitative analysis, AI enables precise identification of medicinal material sources, classification of chemical components, and analysis of biopharmaceutical properties. In inference analysis, AI’s capabilities extend to delineating efficacious substances and their mechanisms of action, analyzing interactions from a systems biology perspective, and discovering new indications and therapeutic potentials. The study introduces two advanced AI-driven models that underscore the significant role of AI in TCM research: the “component-syndrome” model, an end-to-end data-driven approach that integrates and analyzes complex datasets to predict syndrome-component correlations, and the IVIVC model for oral formulations, which mechanistically models the dissolution, absorption, and efficacy of TCM components, providing a predictive framework for their clinical efficacy.

Ultimately, this research propels forward the integration of traditional medicinal knowledge with modern computational techniques, laying a methodological foundation for future endeavors at the intersection of AI and TCM. This balanced approach promises innovative advancements that merge traditional insights with scientific inquiry, underscoring AI’s potential to enrich the TCM field and marking a step towards its enhanced scientific understanding and broader application.

Acknowledgments

This research was supported by the National Natural Science Foundation of China (82230117). The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.

Compliance with ethics guidelines

Jingqi Zeng and Xiaobin Jia declare that they have no conflict of interest or financial conflicts to disclose.

References

[1]

Unschuld PU. Traditional Chinese medicine: some historical and epistemological reflections. Soc Sci Med 1986; 24(12):1023-9.

[2]

Prance SE, Dresser A, Wood C, Fleming J, Aldridge D, Pietroni PC. Research on traditional Chinese acupuncture—science or myth: a review. J R Soc Med 1988; 10(10):588-90.

[3]

Xiong Y, Li NX, Duan N, Liu B, Zhu H, Zhang C, et al. Traditional Chinese medicine in treating influenza: from basic science to clinical applications. Front Pharmacol 2020; 11:575803.

[4]

Zhao Z, Li Y, Zhou L, Zhou X, Xie B, Zhang W, et al. Prevention and treatment of COVID-19 using traditional Chinese medicine: a review. Phytomedicine 2021; 85:153308.

[5]

Lyu M, Fan G, Xiao G, Wang T, Xu D, Gao J, et al. Traditional Chinese medicine in COVID-19. Acta Pharm Sin B 2021; 11(11):3337-63.

[6]

An X, Zhang Y, Duan L, Jin D, Zhao S, Zhou RR, et al. The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19. Biomed Pharmacother 2021; 137:111267.

[7]

Jiang W. Therapeutic wisdom in traditional Chinese medicine: a perspective from modern science. Trends Pharmacol Sci 2005; 26(11):558-63.

[8]

Liu B. Utilizing big data to build personalized technology and system of diagnosis and treatment in traditional Chinese medicine. Front Med 2014; 8 (3):272-8.

[9]

Chu X, Sun B, Huang Q, Peng S, Zhou Y, Zhang Y. Quantitative knowledge presentation models of traditional Chinese medicine (TCM): a review. Artif Intell Med 2020; 103:101810.

[10]

Tu Y. Artemisinin—a gift from traditional Chinese medicine to the world (Nobel Lecture). Angew Chem Int Ed 2016; 55(35):10210-26.

[11]

Hu C, Xu G. Metabolomics and traditional Chinese medicine. TrAC Trends Anal Chem 2014; 61:207-14.

[12]

Wang T, Liu J, Luo X, Hu L, Lu H. Functional metabolomics innovates therapeutic discovery of traditional Chinese medicine derived functional compounds. Pharmacol Ther 2021; 224:107824.

[13]

Zhang A, Sun H, Yan G, Han Y, Zhao QQ, Wang XJ. Chinmedomics: a powerful approach integrating metabolomics with serum pharmacochemistry to evaluate the efficacy of traditional Chinese medicine. Engineering 2019; 5 (1):60-8.

[14]

Zhang B, Li Y, Zhang Y, Li Z, Bi T, He Y, et al. ITPI: initial transcription processbased identification method of bioactive components in traditional Chinese medicine formula. Evid Based Complement Alternat Med 2016; 2016:8250323.

[15]

He H, Sun W, Chang J, Hu S, Yang J, Yi X, et al. Multi-component immune knockout: a strategy for studying the effective components of traditional Chinese medicine. J Chromatogr A 2023; 1692:463853.

[16]

Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997; 23(1-3):3-25.

[17]

Jiao X, Jin X, Ma Y, Yang Y, Li J, Liang L, et al. A comprehensive application: molecular docking and network pharmacology for the prediction of bioactive constituents and elucidation of mechanisms of action in component-based Chinese medicine. Comput Biol Chem 2021; 90:107402.

[18]

Sun C, Huang J, Tang R, Li M, Yuan H, Wang Y, et al. CPMCP: a database of Chinese patent medicine and compound prescription. Database 2022; 2022:baac073.

[19]

Wu Y, Zhang F, Yang K, Fang S, Bu D, Li H, et al. SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping. Nucleic Acids Res 2018; 47(D1):D1110-7.

[20]

Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 2014; 6(1):13.

[21]

Zhang Y, Li X, Shi Y, Chen T, Xu Z, Wang P, et al. ETCM v2.0: an update with comprehensive resource and rich annotations for traditional Chinese medicine. Acta Pharm Sin B 2023; 13(6):2559-71.

[22]

Huang L, Xie D, Yu Y, Liu H, Shi Y, Shi T, et al. TCMID 2.0: a comprehensive resource for TCM. Nucleic Acids Res 2017; 46(D1):D1117-20.

[23]

Chen Q, Springer L, Gohlke BO, Goede A, Dunkel M, Abel R, et al. SuperTCM: a biocultural database combining biological pathways and historical linguistic data of Chinese Materia Medica for drug development. Biomed Pharmacother 2021; 144:112315.

[24]

Lv Q, Chen G, He H, Yang Z, Zhao L, Chen HY, et al. TCMBank: bridges between the largest herbal medicines, chemical ingredients, target proteins, and associated diseases with intelligence text mining. Chem Sci 2023; 14 (39):10684-701.

[25]

Fang S, Dong L, Liu L, Guo JC, Zhao LH, Zhang JY, et al. HERB: a highthroughput experiment- and reference-guided database of traditional Chinese medicine. Nucleic Acids Res 2020; 49(D1):D1197-206.

[26]

Zeng X, Zhang P, Wang Y, Qin C, Chen S, He W, et al. CMAUP: a database of collective molecular activities of useful plants. Nucleic Acids Res 2018; 47 (D1):D1118-27.

[27]

Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med 2013; 11(2):110-20.

[28]

Sadri A. Is target-based drug discovery efficient? Discovery and ‘‘off-target” mechanisms of all drugs. J Med Chem 2023; 66(18):12651-77.

[29]

Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature 2021; 596 (7873):583-9.

[30]

Zhang C, Xu J, Tang R, Yang J, Wang W, Yu X, et al. Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment. J Hematol Oncol 2023; 16(1):114.

[31]

Lam R, Sanchez-Gonzalez A, Willson M, Wirnsberger P, Fortunato M, Alet F, et al. Learning skillful medium-range global weather forecasting. Science 2023; 382(6677):1416-21.

[32]

Ng AY, Oberije CJ, Ambrózay É, Szabó E, Serf}oz}o O, Karpati E, et al. Prospective implementation of AI-assisted screen reading to improve early detection of breast cancer. Nat Med 2023;29(12):3044-9.

[33]

Kurtz DM, Esfahani MS, Scherer F, Soo J, Jin MC, Liu CL, et al. Dynamic risk profiling using serial tumor biomarkers for personalized outcome prediction. Cell 2019; 178(3):699-713.e19.

[34]

Jiang M, Zhao S, Yang S, Lin X, He X, Wei X, et al. An ‘‘essential herbal medicine”—licorice: a review of phytochemicals and its effects in combination preparations. J Ethnopharmacol 2020; 249:112439.

[35]

Mancuso C, Santangelo R. Panax ginseng and Panax quinquefolius: from pharmacology to toxicology. Food Chem Toxicol 2017; 107:362-72.

[36]

Fu J, Wang Z, Huang L, Zheng S, Wang D, Chen S, et al. Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother Res 2014; 28(9):1275-83.

[37]

Still J. Use of animal products in traditional Chinese medicine: environmental impact and health hazards. Complement Ther Med 2003; 11(2):118-22.

[38]

Zhong X, Di Z, Xu Y, Liang Q, Feng K, Zhang Y, et al. Mineral medicine: from traditional drugs to multifunctional delivery systems. Chin Med 2022; 17(1):21.

[39]

Paterson RRM. Cordyceps—a traditional Chinese medicine and another fungal therapeutic biofactory? Phytochemistry 2008; 69(7):1469-95.

[40]

Ma B, Ma J, Li B, Tao Q, Gan J, Yan Z. Effects of different harvesting times and processing methods on the quality of cultivated Fritillaria cirrhosa D. Don. Food Sci Nutr 2021; 9(6):2853-61.

[41]

Wang S, Kang C, Guo L, Garran TA. The mechanism of formation of Daodi herbs. In: Huang L, editor. Molecular pharmacognosy. Singapore: Springer; 2019. p. 293-303.

[42]

Wu X, Wang S, Lu J, Jing Y, Li M, Cao J, et al. Seeing the unseen of Chinese herbal medicine processing (Paozhi): advances in new perspectives. Chin Med 2018; 13(1):4.

[43]

Roy A, Khan A, Ahmad I, Alghamdi S, Rajab BS, Babalghith AO, et al. Flavonoids a bioactive compound from medicinal plants and its therapeutic applications. BioMed Res Int 2022; 2022:5445291.

[44]

Zhang Y, Hao R, Chen J, Li S, Huang K, Cao H, et al. Health benefits of saponins and its mechanisms: perspectives from absorption, metabolism, and interaction with gut. Crit Rev Food Sci Nutr 2023; 22:1-22.

[45]

Xu D, Hu M, Wang Y, Cui YL. Antioxidant activities of quercetin and its complexes for medicinal application. Molecules 2018; 24(6):1123.

[46]

Upadhyay R, Rao LJM. An outlook on chlorogenic acids—occurrence, chemistry, technology, and biological activities. Crit Rev Food Sci Nutr 2013; 53(9):968-84.

[47]

Dong X, Fu J, Yin X, Cao S, Li X, Lin L, et al. Emodin: a review of its pharmacology, toxicity and pharmacokinetics. Phytother Res 2016; 30(8):1207-18.

[48]

Ma C, Jiang Y, Wang Y, Xu R. The latest research advances of Danggui Buxue Tang as an effective prescription for various diseases: a comprehensive review. Curr Med Sci 2022; 42(5):913-24.

[49]

Gao Q, Li J, Cheung JKH, Duan J, Ding A, Cheung AWH, et al. Verification of the formulation and efficacy of Danggui Buxue Tang (a decoction of Radix Astragali and Radix Angelicae Sinensis): an exemplifying systematic approach to revealing the complexity of Chinese herbal medicine formulae. Chin Med 2007; 2(1):12.

[50]

Zhou X, Seto SW, Chang D, Kiat H, Razmovski-Naumovski V, Chan K, et al. Synergistic effects of Chinese herbal medicine: a comprehensive review of methodology and current research. Front Pharmacol 2016; 7:206424.

[51]

Muluye RA, Bian Y, Alemu PN. Anti-inflammatory and antimicrobial effects of heat-clearing Chinese herbs: a current review. J Tradit Complement Med 2014; 4(2):93-8.

[52]

Zhou R, Zheng Y, An X, Jin D, Lian F, Tong X. Dosage modification of traditional Chinese medicine prescriptions: an analysis of two randomized controlled trials. Front Pharmacol 2021; 12:732698.

[53]

Bai X, Zhu C, Chen J, Jiang X, Jin Y, Shen R, et al. Recent progress on mass spectrum based approaches for absorption, distribution, metabolism, and excretion characterization of traditional Chinese medicine. Curr Drug Metab 2022; 23(2):99-112.

[54]

Li C, Jia W, Yang J, Cheng C, Olaleye OE. Multi-compound and drugcombination pharmacokinetic research on Chinese herbal medicines. Acta Pharmacol Sin 2022; 43(12):3080-95.

[55]

Calabrese EJ. The emergence of the dose-response concept in biology and medicine. Int J Mol Sci 2016; 17(12):2034.

[56]

Moreno García V, Olmos D, Gomez-Roca C, Cassier PA, Morales-Barrera R, Del Conte G, et al. Dose-response relationship in phase I clinical trials: a European Drug Development Network (EDDN) collaboration study. Clin Cancer Res 2014; 20(22):5663-71.

[57]

Moffett DB, Mumtaz MM, Sullivan DW, Whittaker MH. General considerations of dose-effect and dose-response relationships. In: Nordberg GF, Costa M, editors. Handbook on the toxicology of metals. Academic Press; 2022. p. 299-317.

[58]

Xu H, Li S, Liu J, Cheng J, Kang L, Li W, et al. Bioactive compounds from Huashi Baidu decoction possess both antiviral and anti-inflammatory effects against COVID-19. Proc Natl Acad Sci USA 2023; 120(18):e2301775120.

[59]

Chen Z, Cao Y, He S, Qiao Y. Development of models for classification of action between heat-clearing herbs and blood-activating stasis-resolving herbs based on theory of traditional Chinese medicine. Chin Med 2018; 13(1):12.

[60]

Yan S, Lu Y, Zhang G, Li X, Wang Z, Yao C, et al. Effect of heat-clearing and detoxifying Chinese medicines combined with conventional therapy on mild hand, foot, and mouth disease with fever: an individual patient data metaanalysis. Medicine 2020; 99(23):e20473.

[61]

Al-Khayri JM, Sahana GR, Nagella P, Joseph BV, Alessa FM, Al-Mssallem MQ. Flavonoids as potential anti-inflammatory molecules: a review. Molecules 2022; 27(9):2901.

[62]

Choy KW, Murugan D, Leong X, Abas R, Alias A, Mustafa MR. Flavonoids as natural anti-inflammatory agents targeting nuclear factor-kappa B (NFjB) signaling in cardiovascular diseases: a mini review. Front Pharmacol 2019; 10:491923.

[63]

Liang H, Ruan H, Ouyang Q, Lai L. Herb-target interaction network analysis helps to disclose molecular mechanism of traditional Chinese medicine. Sci Rep 2016; 6(1):1-10.

[64]

Gu S, Lai L. Associating 197 Chinese herbal medicine with drug targets and diseases using the similarity ensemble approach. Acta Pharmacol Sin 2020; 41 (3):432-8.

[65]

Zhu Y, Ouyang Z, Du H, Wang M, Wang J, Sun H, et al. New opportunities and challenges of natural products research: when target identification meets single-cell multiomics. Acta Pharm Sin B 2022; 12(11):4011-39.

[66]

Zhang J, Liu Y, Xu Y. Soothing liver-qi stagnation method for cancer-related depression: a protocol for systematic review and meta-analysis. Medicine 2020; 99(43):e22797.

[67]

Zhai X, Wang X, Wang L, Xiu L, Wang W, Pang X. Treating different diseases with the same method—a traditional Chinese medicine concept analyzed for its biological basis. Front Pharmacol 2020; 11:547328.

[68]

Xu L, Chen C. Mechanism and basis of traditional Chinese medicine against obesity: prevention and treatment strategies. Front Pharmacol 2021; 12:615895.

[69]

Liu T, Qin M, Xiong X, Lai X, Gao Y. Multi-omics approaches for deciphering the complexity of traditional Chinese medicine syndromes in stroke: a systematic review. Front Pharmacol 2022; 13:980650.

[70]

Lu Y, Fang Z, Zeng T, Li M, Chen Q, Zhang H, et al. Chronic hepatitis B: dynamic change in traditional Chinese medicine syndrome by dynamic network biomarkers. Chin Med 2019; 14(1):52.

[71]

Sun Y, Zhao Y, Xue SA, Chen J. The theory development of traditional Chinese medicine constitution: a review. J Tradit Chin Med Sci 2017; 5(1):16-28.

[72]

Yap SY, Ng FL, Subramaniam M, Lim YM, Foo CN.Traditional Chinese medicine body constitutions as predictors for depression: a systematic review and meta-analysis. Behav Sci 2022; 12(11):423.

[73]

Liang X, Wang Q, Jiang Z, Li Z, Zhang M, Yang P, et al. Clinical research linking traditional Chinese medicine constitution types with diseases: a literature review of 1639 observational studies. J Tradit Chin Med 2020; 40(4):690-702.

[74]

Li M, Mo S, Lv Y, Tang Z, Dong J. A study of traditional Chinese medicine body constitution associated with overweight, obesity, and underweight. Evid Based Complement Alternat Med 2017; 2017:7361896.

[75]

Hu X, Su S. An overview of epigenetics in Chinese medicine researches. Chin J Integr Med 2017; 23(9):714-20.

[76]

Teijido O. Epigenetic mechanisms in the regulation of drug metabolism and transport. In: Cacabelos R, editor. Pharmacoepigenetics. Academic Press; 2019. p. 113-28.

[77]

Wang W, Li H, Shi Y, Zhou J, Khan GJ, Zhu J, et al. Targeted intervention of natural medicinal active ingredients and traditional Chinese medicine on epigenetic modification: possible strategies for prevention and treatment of atherosclerosis. Phytomedicine 2023; 122:155139.

[78]

Wang Q. Individualized medicine, health medicine, and constitutional theory in Chinese medicine. Front Med 2012; 6(1):1-7.

[79]

Sang X, Wang Z, Liu S, Wang R. Relationship between traditional Chinese medicine (TCM) constitution and TCM syndrome in the diagnosis and treatment of chronic diseases. Chin Med Sci J 2018; 33(2):114-9.

[80]

Yu R, Zhao X, Li L, Ni C, Yang Y, Han Y, et al. Consistency between traditional Chinese medicine constitution-based classification and genetic classification. J Tradit Chin Med Sci 2015; 2(4):248-57.

[81]

Zhao S, Tang Y, Wang R, Najafi M. Mechanisms of cancer cell death induction by paclitaxel: an updated review. Apoptosis 2022; 27(9-10):647-67.

[82]

Wang K, Chen Q, Shao Y, Yin S, Liu C, Liu Y, et al. Anticancer activities of TCM and their active components against tumor metastasis. Biomed Pharmacother 2020; 133:111044.

[83]

Qi F, Zhao L, Zhou A, Zhang B, Li A, Wang Z, et al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Biosci Trends 2015; 9(1):16-34.

[84]

Yao CL, Zhang JQ, Li JY, Wei W, Wu S, Guo D. Traditional Chinese medicine (TCM) as a source of new anticancer drugs. Nat Prod Rep 2021; 38(9):1618-33.

[85]

Sheik A, Kim K, Varaprasad GL, Lee H, Kim S, Kim E, et al. The anti-cancerous activity of adaptogenic herb Astragalus membranaceus. Phytomedicine 2021; 91:153698.

[86]

Bai F, Huang Z, Luo J, Qiu Y, Huang S, Huang C, et al. Bibliometric and visual analysis in the field of traditional Chinese medicine in cancer from 2002 to 2022. Front Pharmacol 2023; 14:1164425.

[87]

Hu Q, Sun Y, Lau E, Zhao M, Su SB. Advances in synergistic combinations of Chinese herbal medicine for the treatment of cancer. Curr Cancer Drug Targets 2016; 16(4):346-56.

[88]

Yen C, Zhao F, Yu Z, Zhu X, Li CG. Interactions between natural products and tamoxifen in breast cancer: a comprehensive literature review. Front Pharmacol 2022; 13:847113.

[89]

Ali M, Wani SUD, Salahuddin M, Manjula SN, Mruthunjaya K, Dey T, et al. Recent advance of herbal medicines in cancer—a molecular approach. Heliyon 2023; 9(2):e13684.

[90]

Xia X, Cole PC, Cai T, Cai Y. Effect of traditional Chinese medicine components on multidrug resistance in tumors mediated by P-glycoprotein. Oncol Lett 2017; 13(6):3989-96.

[91]

Birch S, Alraek T, Lee MS, Kim TH. Descriptions of qi deficiency and qi stagnation in traditional East Asian medicine: a comparison of Asian and Western sources. Eur J Integr Med 2022; 55:102180.

[92]

Ji Q, Luo Y, Wang W, Liu X, Li Q, Su S. Research advances in traditional Chinese medicine syndromes in cancer patients. J Integr Med 2015; 14(1):12-21.

[93]

Echle A, Rindtorff NT, Brinker TJ, Luedde T, Pearson AT, Kather JN. Deep learning in cancer pathology: a new generation of clinical biomarkers. Br J Cancer 2021; 124(4):686-96.

[94]

Hristova VA, Chan DW. Cancer biomarker discovery and translation: proteomics and beyond. Expert Rev Proteomics 2019; 16(2):93-103.

[95]

Kumar RR, Kumar A, Chuang CH, Shaikh MO. Recent advances and emerging trends in cancer biomarker detection technologies. Ind Eng Chem Res 2023; 62(14):5691-713.

[96]

Liao X, Bu Y, Jia Q. Traditional Chinese medicine as supportive care for the management of liver cancer: past, present, and future. Genes Dis 2020; 7(3):370-9.

[97]

Wang M, Ye Q, Mao D, Li H. Research progress in liver-regenerating microenvironment and DNA methylation in hepatocellular carcinoma: the role of traditional Chinese medicine. Med Sci Monit 2020; 26:e920310-1.

[98]

Wang S, Long S, Wu W. Application of traditional Chinese medicines as personalized therapy in human cancers. Am J Chin Med 2018; 46(5):953-70.

[99]

Meng C, Wang P, Hao Z, Gao Z, Li Q, Gao H, et al. Ecological and health risk assessment of heavy metals in soil and Chinese herbal medicines. Environ Geochem Health 2022; 44(3):817-28.

[100]

Chen W, Yang Y, Fu K, Zhang D, Wang Z. Progress in ICP-MS analysis of minerals and heavy metals in traditional medicine. Front Pharmacol 2022; 13:891273.

[101]

Mullowney MW, Duncan KR, Elsayed SS, Garg N, van der Hooft JJJ, Martin NI, et al. Artificial intelligence for natural product drug discovery. Nat Rev Drug Discov 2023; 22(11):1-22.

[102]

Chen Y, Yao F, Ming K, Wang D, Hu Y, Liu J. Polysaccharides from traditional Chinese medicines: extraction, purification, modification, and biological activity. Molecules 2016; 21(12):1705.

[103]

Yue B, Zong G, Tao R, Wei Z, Lu Y. Crosstalk between traditional Chinese medicine-derived polysaccharides and the gut microbiota: a new perspective to understand traditional Chinese medicine. Phytother Res 2022; 36(11):4125-38.

[104]

Liu M, Wang Y, Liu Y, Ruan R. Bioactive peptides derived from traditional Chinese medicine and traditional Chinese food: a review. Food Res Int 2016; 89:63-73.

[105]

Zhang Y, Liu L, Zhang M, Li S, Wu J, Sun Q, et al. The research progress of bioactive peptides derived from traditional natural products in China. Molecules 2022; 28(17):6421.

[106]

Afshar Bakshloo M, Kasianowicz JJ, Pastoriza-Gallego M, Mathé J, Daniel R, Piguet F, et al. Nanopore-based protein identification. J Am Chem Soc 2022; 144(6):2716-25.

[107]

Yu M, Choi YH, Tu J. RNA drugs and RNA targets for small molecules: principles, progress, and challenges. Pharmacol Rev 2020; 72(4):862-98.

[108]

Chen X, Dai GH, Ren ZM, Tong YL, Yang F, Zhu YQ. Identification of dietetically absorbed rapeseed (Brassica campestris L.) bee pollen microRNAs in serum of mice. BioMed Res Int 2016; 2016:5413849.

[109]

Gu C, Yu X, Tang X, Gong L, Tan J, Zhang Y, et al. Lycium barbarum L.-derived miR162a functions on osteoporosis through directly promoting osteoblast formation. Engineering. In press.

[110]

Kim J, Li S, Zhang S, Wang J. Plant-derived exosome-like nanoparticles and their therapeutic activities. Asian J Pharm Sci 2021; 17(1):53-69.

[111]

Cao M, Yan H, Han X, Weng L, Wei Q, Sun X, et al. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth. J Immunother Cancer 2019; 7(1):1.

[112]

Seo K, Yoo JH, Kim J, Min SJ, Heo DN, Kwon IK, et al. Ginseng-derived exosome-like nanovesicles extracted by sucrose gradient ultracentrifugation to inhibit osteoclast differentiation. Nanoscale 2023; 15(12):5798-808.

[113]

Dad HA, Gu W, Zhu Q, Huang LQ, Peng LH. Plant exosome-like nanovesicles: emerging therapeutics and drug delivery nanoplatforms. Mol Ther 2020; 29(1):13-31.

[114]

Pottel J, Armstrong D, Zou L, Fekete A, Huang XP, Torosyan H, et al. The activities of drug inactive ingredients on biological targets. Science 2020; 369(6502):403-13.

[115]

Takizawa Y, Goto N, Furuya T, Hayashi M. Influence of pharmaceutical excipients on the membrane transport of a P-glycoprotein substrate in the rat small intestine. Eur J Drug Metab Pharmacokinet 2020; 45(5):645-52.

[116]

Leclercq L. Interactions between cyclodextrins and cellular components: towards greener medical applications? Beilstein J Org Chem 2016; 12:2644-62.

[117]

Miron A, Aprotosoaie AC, Trifan A, Xiao J. Flavonoids as modulators of metabolic enzymes and drug transporters. Ann N Y Acad Sci 2017; 1398(1):152-67.

[118]

Liu M, Zhang G, Zhou K, Wen J, Zheng F, Sun L, et al. Structural characterization, antioxidant activity, and the effects of Codonopsis pilosula polysaccharides on the solubility and stability of flavonoids. J Pharm Biomed Anal 2023; 229:115368.

[119]

Terada T. Molecular mechanisms for biliary phospholipid and drug efflux mediated by ABCB4 and bile salts. BioMed Res Int 2014; 2014:954781.

[120]

Chiang LY. Bile acid metabolism and signaling. Compr Physiol 2013; 3(3):1191.

[121]

Bihari S, Bannard-Smith J, Bellomo R. Albumin as a drug: its biological effects beyond volume expansion. Crit Care Resusc 2020; 22(3):257-65.

[122]

Plana D, Palmer AC, Sorger PK. Independent drug action in combination therapy: implications for precision oncology. Cancer Discov 2022; 12(3):606-24.

[123]

Calzetta L, Koziol-White C. Pharmacological interactions: synergism, or not synergism, that is the question. Curr Res Pharmacol Drug Discov 2021; 2:100046.

[124]

Liang L, Jin X, Li J, Li R, Jiao X, Ma Y, et al. A comprehensive review of pharmacokinetics and pharmacodynamics in animals: exploration of interaction with antibiotics of Shuang-Huang-Lian preparations. Curr Top Med Chem 2022; 22(2):83-94.

[125]

Yao J, Li Y, Jin Y, Chen Y, Tian L, He W. Synergistic cardioprotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-jB/ NLRP3 and PGC1a/SIRT3 pathways. Int Immunopharmacol 2021; 96:107728.

[126]

Kumari N, Dalal V, Kumar P, Rath SN. Antagonistic interaction between TTAA2 and paclitaxel for anti-cancer effects by complex formation with T-type calcium channel. J Biomol Struct Dyn 2022; 40(6):2395-406.

[127]

Zuo GY, Fu RC, Yu W, Zhang YL, Wang GC. Potentiation effects by usnic acid in combination with antibiotics on clinical multi-drug resistant isolates of methicillin-resistant Staphylococcus aureus (MRSA). Med Chem Res 2018; 27(5):1443- 2148.

[128]

Foucquier J, Guedj M. Analysis of drug combinations: current methodological landscape. Pharmacol Res Perspect 2015; 3(3):e00149.

[129]

Zheng S, Wang W, Aldahdooh J, Malyutina A, Shadbahr T, Tanoli Z, et al. SynergyFinder plus: toward better interpretation and annotation of drug combination screening datasets. Genomics Proteomics Bioinf 2022; 20(3):587-96.

[130]

Malyutina A, Majumder MM, Wang W, Pessia A, Heckman CA, Tang J. Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer. PLOS Comput Biol 2019; 15(5):e1006752.

[131]

Kong W, Midena G, Chen Y, Athanasiadis P, Wang T, Rousu J, et al. Systematic review of computational methods for drug combination prediction. Comput Struct Biotechnol J 2021; 20:2807-14.

[132]

Li J, Xu H, McIndoe RA. A novel network based linear model for prioritization of synergistic drug combinations. PLoS One 2022; 17(4):e0266382.

[133]

Cheng F, Kovács IA, Barabási AL. Network-based prediction of drug combinations. Nat Commun 2019;10(1):1-11.

[134]

Gan X, Shu Z, Wang X, Yan D, Li J, Ofaim S, et al. Network medicine framework reveals generic herb-symptom effectiveness of traditional Chinese medicine. Sci Adv 2023; 9(43):eadh0215.

[135]

Li L, Zheng R, Sun R. Multicomponent self-assembly based on bioactive molecules of traditional Chinese medicine (TCM). Pharmacol Res Modern Chin Med 2022; 4:100158.

[136]

Huang J, Zhu Y, Xiao H, Liu J, Li S, Zheng Q, et al. Formation of a traditional Chinese medicine self-assembly nanostrategy and its application in cancer: a promising treatment. Chin Med 2023; 18(1):66.

[137]

Lin X, Huang X, Tian X, Yuan Z, Lu J, Nie X, et al. Natural small-molecule-based carrier-free self-assembly library originated from traditional Chinese herbal medicine. ACS Omega 2022; 7(48):43510-21.

[138]

Gao Y, Dong Y, Guo Q, Wang H, Feng M, Yan Z, et al. Study on supramolecules in traditional Chinese medicine decoction. Molecules 2022; 27(10):3268.

[139]

Parayath NN, Amiji MM. Therapeutic targeting strategies using endogenous cells and proteins. J Control Release 2017; 258:81-94.

[140]

Asrorov AM, Gu Z, Li F, Liu L, Huang Y. Biomimetic camouflage delivery strategies for cancer therapy. Nanoscale 2021; 13(19):8693-706.

[141]

Khatoon SS, Chen Y, Zhao H, Lv F, Liu L, Wang S. In situ self-assembly of conjugated polyelectrolytes for cancer targeted imaging and photodynamic therapy. Biomater Sci 2020; 21;8(8):2156-63.

[142]

Kim J, Lee S, Kim Y, Choi M, Lee I, Kim E, et al. In situ self-assembly for cancer therapy and imaging. Nat Rev Mater 2023; 8(11):1-16.

[143]

Sun X, Yang X, Chen Y, Sun J, He Z, Zhang S, et al. In situ self-assembled nanomedicines for cancer treatment. Chem Eng J 2023; 466:143365.

[144]

Bag BG, Majumdar R. Self-assembly of renewable nano-sized triterpenoids. Chem Rec 2017; 17(9):841-73.

[145]

Zhi K, Zhao H, Yang X, Zhang H, Wang J, Wang J, et al. Natural product gelators and a general method for obtaining them from organisms. Nanoscale 2018; 10(8):3639-43.

[146]

Hou Y, Chen M, Ruan H, Sun Z, Wu H, Xu X, et al. A new supramolecular natural product gel based on self-assembled pomolic acid from traditional Chinese medicine. Colloid Interface Sci Commun 2021; 46:100583.

[147]

Zheng J, Fan R, Wu H, Yao H, Yan Y, Liu J, et al. Directed self-assembly of herbal small molecules into sustained release hydrogels for treating neural inflammation. Nat Commun 2019; 10(1):1604.

[148]

Li T, Wang P, Guo W, Huang X, Tian X, Wu G, et al. Natural berberine-based Chinese herb medicine assembled nanostructures with modified antibacterial application. ACS Nano 2019; 13(6):6770-81.

[149]

Wang P, Guo W, Huang G, Zhen J, Li Y, Li T, et al. Berberine-based heterogeneous linear supramolecules neutralized the acute nephrotoxicity of aristolochic acid by the self-assembly strategy. ACS Appl Mater Interfaces 2021; 13(28):32729-42.

[150]

Wang Z, Lu J, Yuan Z, Pi W, Huang X, Lin X, et al. Natural carrier-free binary small molecule self-assembled hydrogel synergize antibacterial effects and promote wound healing by inhibiting virulence factors and alleviating the inflammatory response. Small 2023; 19(5):e2205528.

[151]

An J, Liu M, Din Z, Xie F, Cai J. Toward function starch nanogels by selfassembly of polysaccharide and protein: from synthesis to potential for polyphenol delivery. Int J Biol Macromol 2023; 247:125697.

[152]

Morrow BH, Payne GF, Shen J. PH-responsive self-assembly of polysaccharide through a rugged energy landscape. J Am Chem Soc 2015; 137(40):13024-30.

[153]

Liu Y, Yang R, Liu J, Meng D, Zhou Z, Zhang Y, et al. Fabrication, structure, and function evaluation of the ferritin based nano-carrier for food bioactive compounds. Food Chem 2019; 299:125097.

[154]

Yu B, Sun Z, Li X, Qv A, Sohail M, Li Y, et al. Research progress of novel drug delivery systems of Chinese medicine monomers based on natural silk fibroin: a mini-review. Curr Drug Deliv 2023; 20(3):211-22.

[155]

Zhu J, Li Z, Wu C, Fan G, Li T, Shen D, et al. Insight into the self-assembly behavior of a-zein by multi-spectroscopic and molecular simulations: an example of combination with the main component of jujube peel pigments— rutin. Food Chem 2023; 404:134684.

[156]

Zhou Q, Wang X, Li J, Wu YR, Wang W, Yu ZY, et al. Self-assembly and interaction mechanisms of edible dock protein and flavonoids regulated by the phenolic hydroxyl position. Food Chem 2023; 424:136383.

[157]

Huang Y, Li J, Liu Y, Gantumur MA, Sukhbaatar N, Zhao P, et al. Improving gas-water interface properties and bioactivities of a-lactalbumin induced by three structurally different saponins. Food Hydrocoll 2023; 138:108463.

[158]

Olesen NE, Westh P, Holm R. Displacement of drugs from cyclodextrin complexes by bile salts: a suggestion of an intestinal drug-solubilizing capacity from an in vitro model. J Pharm Sci 2016; 105(9):2640-7.

[159]

Pigliacelli C, Belton P, Wilde P, Qi S. Probing the molecular interactions between pharmaceutical polymeric carriers and bile salts in simulated gastrointestinal fluids using NMR spectroscopy. J Colloid Interface Sci 2019; 551:147-54.

[160]

Cui L, Sun E, Zhang Z, Tan XB, Wei YJ, Jin X, et al. Enhancement of epimedium fried with suet oil based on in vivo formation of self-assembled flavonoid compound nanomicelles. Molecules 2012; 17(11):12984-96.

[161]

Li X, Geng M. Probing the binding of procyanidin B3 to trypsin and pepsin: a multi-technique approach. Int J Biol Macromol 2016; 85:168-78.

[162]

Li X, Liu H, Wu X, Xu R, Ma X, Zhang C, et al. Exploring the interactions of naringenin and naringin with trypsin and pepsin: experimental and computational modeling approaches. Spectrochim Acta A Mol Biomol Spectrosc 2021; 258:119859.

[163]

Martinez-Gonzalez AI, Díaz-Sánchez ÁG, Vargas-Requena CL, et al. Polyphenolic compounds and digestive enzymes: in vitro non-covalent interactions. Molecules 2017;22(4):669.

[164]

Li M, Hagerman AE. Interactions between plasma proteins and naturally occurring polyphenols. Curr Drug Metab 2013; 14(4):432-45.

[165]

Jiao Q, Wang R, Jiang Y, Liu B. Study on the interaction between active components from traditional Chinese medicine and plasma proteins. Chem Cent J 2018; 12(1):48.

[166]

Tezcaner A, Baran ET, Keskin D. Nanoparticles based on plasma proteins for drug delivery applications. Curr Pharm Des 2016; 22(22):3445-54.

[167]

Mayer EA, Nance K, Chen S. The gut-brain axis. Annu Rev Med 2022; 73(1):439-53.

[168]

Chen Z, Venkat P, Seyfried D, Chopp M, Yan T, Chen J. Brain-heart interaction: cardiac complications after stroke. Circ Res 2017; 121(4):451-68.

[169]

Manea MM, Comsa M, Minca A, Dragos D, Popa C. Brain-heart axis. J Med Life 2015; 8(3):266-71.

[170]

Pavlovsky L, Friedman A. Pathogenesis of stress-associated skin disorders: exploring the brain-skin axis. Curr Probl Dermatol 2007; 35:136-45.

[171]

Marek-Jozefowicz L, Czajkowski R, Borkowska A, Nedoszytko B, Żmijewski MA, Cubała WJ, et al. The brain-skin axis in psoriasis. Int J Mol Sci 2022; 23(2):669.

[172]

Marsland BJ, Trompette A, Gollwitzer ES. The gut-lung axis in respiratory disease. Ann Am Thorac Soc 2015; 12(Suppl 2):S150-6.

[173]

Hashimoto Y, Eguchi A, Wei Y, Shinno-Hashimoto H, Fujita Y, Ishima T, et al. Antibiotic-induced microbiome depletion improves LPS-induced acute lung injury via gut-lung axis. Life Sci 2022; 307:120885.

[174]

Simbrunner B, Trauner M, Reiberger T. Therapeutic aspects of bile acid signalling in the gut-liver axis. Aliment Pharmacol Ther 2021; 54(10):1243-62.

[175]

Ticinesi A, Lauretani F, Tana C, Nouvenne A, Ridolo E, Meschi T. Exercise and immune system as modulators of intestinal microbiome. Exerc Immunol Rev 2019; 25:84-95.

[176]

Mancin L, Wu GD, Paoli A. Gut microbiota-bile acid-skeletal muscle axis. Trends Microbiol 2023; 31(3):254-69.

[177]

Tu Y, Yang R, Xu X, Zhou X. The microbiota-gut-bone axis and bone health. J Leukoc Biol 2021; 110(3):525-37.

[178]

He Y, Chen Y. The potential mechanism of the microbiota-gut-bone axis in osteoporosis: a review. Osteoporos Int 2022; 33(12):2495-506.

[179]

Evenepoel P, Poesen R, Meijers B. The gut-kidney axis. Pediatr Nephrol 2017; 32(11):2005-14.

[180]

Chen YY, Chen DQ, Chen L, Liu JR, Vaziri ND, Guo Y, et al. Microbiomemetabolome reveals the contribution of gut-kidney axis on kidney disease. J Transl Med 2019; 17(1):5.

[181]

Cannata-Andía JB, Martín-Carro B, Martín-Vírgala J, Rodríguez-Carrio J, Bande-Fernández JJ, Alonso-Montes C, et al. Chronic kidney disease-mineral and bone disorders: pathogenesis and management. Calcif Tissue Int 2021; 108(4):410-22.

[182]

Massy ZA, Drueke TB. A new player in the kidney-bone axis: regulation of fibroblast growth factor-23 by renal glycerol-3-phosphate. Kidney Int 2020; 98(5):1074-6.

[183]

Rathi S, Kumar P. Drug-induced liver injury—types and phenotypes. N Engl J Med 2019; 381(14):1395-6.

[184]

Pan X, Zhou J, Chen Y, Xie X, Rao C, Liang J, et al. Classification, hepatotoxic mechanisms, and targets of the risk ingredients in traditional Chinese medicine-induced liver injury. Toxicol Lett 2020; 323:48-56.

[185]

Wang Z, Xu G, Wang H, Zhan X, Gao Y, Chen N, et al. Icariside II, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP 3 inflammasome activation. Acta Pharm Sin B 2020; 10 (9):1619-33.

[186]

Gao Y, Xu G, Ma L, Shi W, Wang Z, Zhan X, et al. Icariside I specifically facilitates ATP or nigericin-induced NLRP 3 inflammasome activation and causes idiosyncratic hepatotoxicity. Cell Commun Signal 2021; 19(1):19.

[187]

Qu L, Liang X, Tian G, Zhang G, Wu Q, Huang X, et al. Efficacy and safety of mulberry twig alkaloids tablet for the treatment of type 2 diabetes: a multicenter, randomized, double-blind, double-dummy, and parallel controlled clinical trial. Diabetes Care 2021; 44(6):1324-33.

[188]

Liu S, Yi Z, Liang Z. Traditional Chinese medicine and separation science. J Sep Sci 2008; 31(11):2113-37.

[189]

Zhao HY, Jiang JG. Application of chromatography technology in the separation of active components from nature derived drugs. Mini Rev Med Chem 2010; 10(13):1223-34.

[190]

Zhang Y, Yu J, Zhang W, Wang Y, He Y, Zhou S, et al. An integrated evidencebased targeting strategy for determining combinatorial bioactive ingredients of a compound herbal medicine Qishen Yiqi dripping pills. J Ethnopharmacol 2018; 219:288-98.

[191]

Xing X, Sun M, Guo Z, Zhao Y, Cai Y, Zhou P, et al. Functional annotation map of natural compounds in traditional Chinese medicines library: TCMs with myocardial protection as a case. Acta Pharm Sin B 2023; 13(9):3802-16.

[192]

Feunang YD, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, et al. ClassyFire: automated chemical classification with a comprehensive, computable taxonomy. J Cheminform 2016; 8:8.

[193]

Schäfer T, Kriege N, Humbeck L, Klein K, Koch O, Mutzel P. Scaffold hunter: a comprehensive visual analytics framework for drug discovery. J Cheminform 2017; 9(1):9.

[194]

Koch MA, Schuffenhauer A, Scheck M, Wetzel S, Casaulta M, Odermatt A, et al. Charting biologically relevant chemical space: a structural classification of natural products (SCONP). Proc Natl Acad Sci USA 2005; 102(48):17272-7.

[195]

Hong J, Wang L, Zhang S, Xie F. Characteristic analysis and similarity calculation of molecular compounds of traditional Chinese medicine. In: DSIT 2020: Proceedings of the 3rd International Conference on Data Science and Information Technology; 2020 Jul 24-26; Xiamen, China. New York City: Association for Computing Machinery; 2020. p. 83-92.

[196]

Wang P, Li K, Tao Y, Li D, Zhang Y, Xu H, et al. TCM-ADMEpred: a novel strategy for poly-pharmacokinetics prediction of traditional Chinese medicine based on single constituent pharmacokinetics, structural similarity, and mathematical modeling. J Ethnopharmacol 2019; 236:277-87.

[197]

Wang Y, Shi X, Li L, Efferth T, Shang D. The impact of artificial intelligence on traditional Chinese medicine. Am J Chin Med 2021; 49(6):1297-314.

[198]

Tian Z, Wang D, Sun X, Fan Y, Guan Y, Zhang N, et al. Current status and trends of artificial intelligence research on the four traditional Chinese medicine diagnostic methods: a scientometric study. Ann Transl Med 2023; 11(3):145.

[199]

Tian D, Chen W, Xu D, Xu L, Xu G, Guo Y, et al. A review of traditional Chinese medicine diagnosis using machine learning: inspection, auscultationolfaction, inquiry, and palpation. Comput Biol Med 2024; 170:108074.

[200]

Wang Y, Jafari M, Tang Y, Tang J. Predicting meridian in Chinese traditional medicine using machine learning approaches. PLOS Comput Biol 2019; 15(11):e1007249.

[201]

Zhang J, Fang Y, Shao X, Chen H, Zhang N, Fan X. The future of molecular studies through the lens of large language models. J Chem Inf Model 2024; 64(3):563-6.

[202]

Zhou L, Liu S, Li C, Sun Y, Zhang Y, Li Y, et al. Natural language processing algorithms for normalizing expressions of synonymous symptoms in traditional Chinese medicine. Evid Based Complement Alternat Med 2021; 2021:6676607.

[203]

Zhang H, Ni W, Li J, Zhang J. Artificial intelligence-based traditional Chinese medicine assistive diagnostic system: validation study. J Med Internet Res 2020; 8(6):e17608.

[204]

Yuan L, Yang L, Zhang S, Xu Z, Qin J, Shi Y, et al. Development of a tongue image-based machine learning tool for the diagnosis of gastric cancer: a prospective multicentre clinical cohort study. EClinicalMedicine 2023; 57:101834.

[205]

Pan Y, Zhang H, Chen Y, Gong X, Yan J, Zhang H. Applications of hyperspectral imaging technology combined with machine learning in quality control of traditional Chinese medicine from the perspective of artificial intelligence: a review. Crit Rev Anal Chem 2023:1-15.

[206]

Weng H, Chen J, Ou A, Lao Y. Leveraging representation learning for the construction and application of a knowledge graph for traditional Chinese medicine: framework development study. JMIR Med Inform 2022; 10(9):e38414.

[207]

Li D, Qu J, Tian Z, Mou Z, Zhang L, Zhang X. Knowledge-based recurrent neural network for TCM cerebral palsy diagnosis. Evid Based Complement Alternat Med 2022; 2022:7708376.

[208]

Zhao X, Wang Y, Li P, Xu J, Sun Y, Qiu M, et al. The construction of a TCM knowledge graph and application of potential knowledge discovery in diabetic kidney disease by integrating diagnosis and treatment guidelines and real-world clinical data. Front Pharmacol 2023; 14:1147677.

[209]

Jin Y, Ji W, Zhang W, He X, Wang X, Wang X. A KG-enhanced multi-graph neural network for attentive herb recommendation. IEEE/ACM Trans Comput Biol Bioinformatics 2022; 19(5):2560-71.

[210]

Li D, Hu J, Zhang L, Li L, Yin Q, Shi J, et al. Deep learning and machine intelligence: new computational modeling techniques for discovery of the combination rules and pharmacodynamic characteristics of traditional Chinese medicine. Eur J Pharmacol 2022; 933:175260.

[211]

Dong X, Zheng Y, Shu Z, Chang K, Xia J, Zhu Q, et al. TCMPR: TCM prescription recommendation based on subnetwork term mapping and deep learning. BioMed Res Int 2022; 2022:4845726.

[212]

Xiong W, Zhu Y, Zeng Q, Du J, Wang K, Luo J, et al. Dose-effect relationship analysis of TCM based on deep Boltzmann machine and partial least squares. Math Biosci Eng 2023; 20(8):14395-413.

[213]

Liang J, Zheng Y, Tong X, Yang N, Dai S. In silico identification of anti-SARSCoV- 2 medicinal plants using cheminformatics and machine learning. Molecules 2022; 28(1):208.

[214]

He S, Yi Y, Hou D, Fu X, Zhang J, Ru X, et al. Identification of hepatoprotective traditional Chinese medicines based on the structure-activity relationship, molecular network, and machine learning techniques. Front Pharmacol 2022; 13:969979.

[215]

Li X, Yao Y, Chen M, Ding H, Liang C, Lv L, et al. Comprehensive evaluation integrating omics strategy and machine learning algorithms for consistency of calculus bovis from different sources. Talanta 2022; 237:122873.

[216]

Zhang S, Yang K, Liu Z, Lai X, Yang Z, Zeng J, et al. DrugAI: a multi-view deep learning model for predicting drug-target activating/inhibiting mechanisms. Brief Bioinform 2023; 24(1):bbac526.

[217]

Wang Z, Li L, Song M, Yan J, Shi J, Yao Y. Evaluating the traditional Chinese medicine (TCM) officially recommended in China for COVID-19 using ontology-based side-effect prediction framework (OSPF) and deep learning. J Ethnopharmacol 2021; 272:113957.

[218]

Liu Z, Luo C, Fu D, Gui J, Zheng Z, Qi L, et al. A novel transfer learning model for traditional herbal medicine prescription generation from unstructured resources and knowledge. Artif Intell Med 2022; 124:102232.

[219]

Gao P, Nasution AK, Yang S, Chen Z, Ono N, Kanaya S, et al. On finding natural antibiotics based on TCM formulae. Methods 2023; 214:35-45.

[220]

Liu K, Chen X, Ren Y, Liu C, Lv T, Liu Y, et al. Multi-target-based polypharmacology prediction (mTPP): an approach using virtual screening and machine learning for multi-target drug discovery. Chem Biol Interact 2022; 368:110239.

[221]

Ma ZW, Tang JW, Liu QH, Mou JY, Qiao R, Du Y, et al. Identification of geographic origins of Morus alba linn. through surfaced enhanced Raman spectrometry and machine learning algorithms. J Biomol Struct Dyn 2023; 41(23):14285-98.

[222]

Yang B, Bao W, Hong S. Alzheimer-compound identification based on data fusion and forgeNet_SVM. Front Aging Neurosci 2022; 14:931729.

[223]

Chen Z, Zhao M, You L, Zheng R, Jiang Y, Zhang X, et al. Developing an artificial intelligence method for screening hepatotoxic compounds in traditional Chinese medicine and Western medicine combination. Chin Med 2022; 17(1):58.

[224]

Sun J, Ni Q, Jiang F, Liu B, Wang J, Zhang L, et al. Discovery and validation of traditional Chinese and Western medicine combination antirheumatoid arthritis drugs based on machine learning (random forest model). BioMed Res Int 2023; 2023:6086388.

[225]

Niu Q, Li H, Tong L, Liu S, Zong W, Zhang S, et al. TCMFP: a novel herbal formula prediction method based on network target’s score integrated with semi-supervised learning genetic algorithms. Brief Bioinform 2023; 24(3):bbad102.

[226]

Liu J, Huang Q, Yang X, Ding C. HPE-GCN: predicting efficacy of tonic formulae via graph convolutional networks integrating traditionally defined herbal properties. Methods 2022; 204:101-9.

[227]

Li JT, Wei YW, Wang MY, Yan CX, Ren X, Fu XJ. Antibacterial activity prediction model of traditional Chinese medicine based on combined datadriven approach and machine learning algorithm: constructed and validated. Front Microbiol 2021; 12:763498.

[228]

Zhang H, Zhang J, Ni W, Jiang Y, Liu K, Sun D, et al. Transformer- and generative adversarial network-based inpatient traditional Chinese medicine prescription recommendation: development study. JMIR Med Inform 2022; 10(5):e35239.

[229]

Yang S, Shen Y, Lu W, Yang Y, Wang H, Li L, et al. Evaluation and identification of the neuroprotective compounds of Xiaoxuming decoction by machine learning: a novel mode to explore the combination rules in traditional Chinese medicine prescription. BioMed Res Int 2019; 2019:6847685.

[230]

Sun M, She S, Chen H, Cheng J, Ji W, Wang D, et al. Prediction model for synergistic anti-tumor multi-compound combinations from traditional Chinese medicine based on extreme gradient boosting, targets and gene expression data. J Bioinform Comput Biol 2022; 20(3):2250016.

[231]

He S, Ye T, Wang R, Zhang C, Zhang X, Sun G, et al. An in silico model for redicting drug-induced hepatotoxicity. Int J Mol Sci 2019; 20(8):1897.

[232]

Zhu S, Liu Q, Qiu S, Dai J, Gao X. DNA barcoding: an efficient technology to authenticate plant species of traditional Chinese medicine and recent advances. Chin Med 2022; 17(1):112.

[233]

Azadnia R, Al-Amidi MM, Mohammadi H, Cifci MA, Daryab A, Cavallo E. An AI based approach for medicinal plant identification using deep CNN based on global average pooling. Agronomy 2022; 12(11):2723.

[234]

McGibbon M, Shave S, Dong J, Gao Y, Houston DR, Xie J, et al. From intuition to AI: evolution of small molecule representations in drug discovery. Brief Bioinform 2023; 25(1):bbad422.

[235]

Yang Q, Ji H, Lu H, Zhang Z. Prediction of liquid chromatographic retention time with graph neural networks to assist in small molecule identification. Anal Chem 2021; 93(4):2200-6.

[236]

Buterez D, Janet JP, Kiddle SJ, Oglic D, Lió P. Transfer learning with graph neural networks for improved molecular property prediction in the multifidelity setting. Nat Commun 2024; 15(1):1517.

[237]

Jia Q, He Q, Yao L, Li M, Lin J, Tang Z, et al. Utilization of physiologically based pharmacokinetic modeling in pharmacokinetic study of natural medicine: an overview. Molecules 2022; 27(24):8670.

[238]

Mullowney MW, Duncan KR, Elsayed SS, Garg N, van der Hooft JJJ, Martin NI, et al. Artificial intelligence for natural product drug discovery. Nat Rev Drug Discov 2023; 22(11):895-916.

[239]

Mastropietro A, Giuseppe P, Jürgen B. Learning characteristics of graph neural networks predicting protein-ligand affinities. Nat Mach Intell 2023; 12 (5):1427-36.

[240]

Zhang P, Wang B, Li S. Network-based cancer precision prevention with artificial intelligence and multi-omics. Sci Bull 2023; 68(12):1219-22.

[241]

Subramanian M, Wojtusciszyn A, Favre L, Boughorbel S, Shan J, Letaief KB, et al. Precision medicine in the era of artificial intelligence: implications in chronic disease management. J Transl Med 2020; 18(1):472.

[242]

Tian S, Wang J, Li Y, Li D, Xu L, Hou T. The application of in silico druglikeness predictions in pharmaceutical research. Adv Drug Deliv Rev 2015; 86:2-10.

[243]

Lin Z, Wang S, Liu Z, Liu B, Xie L, Zhou J. Exploring anti-osteoporosis medicinal herbs using cheminformatics and deep learning approaches. Comb Chem High Throughput Screen 2023; 26(9):1802-11.

[244]

Lee BK, Mayhew EJ, Sanchez-Lengeling B, Wei JN, Qian WW, Little KA, et al. A principal odor map unifies diverse tasks in olfactory perception. Science 2023; 381(6661):999-1006.

[245]

Gautam V, Gupta R, Gupta D, Ruhela A, Mittal A, Mohanty SK, et al. DeepGraphh: AI-driven web service for graph-based quantitative structure- activity relationship analysis. Brief Bioinform 2022; 23(5):bbac288.

[246]

Morehouse NJ, Clark TN, McMann EJ, van Santen JA, Haeckl FPJ, Gray CA, et al. Annotation of natural product compound families using molecular networking topology and structural similarity fingerprinting. Nat Commun 2023; 14(1):308.

[247]

Li Z, He X. Physiologically based in vitro models to predict the oral dissolution and absorption of a solid drug delivery system. Curr Drug Metab 2015; 16(9):777-806.

[248]

Grimstein M, Yang Y, Zhang X, Grillo J, Huang SM, Zineh I, et al. Physiologically based pharmacokinetic modeling in regulatory science: an update from the U.S. Food and Drug Administration’s office of clinical pharmacology. J Pharm Sci 2019; 108(1):21-5.

[249]

Mo Y, Yang Y, Zeng J, Ma W, Guan Y, Guo J, et al. Enhancing the biopharmacological characteristics of asperosaponin VI: unveiling dynamic self-assembly phase transitions in the gastrointestinal environment. Int J Nanomedicine 2023; 18:7335-58.

[250]

Yang B, Wu X, Zeng J, Song J, Qi T, Yang Y, et al. A multi-component nano-codelivery system utilizing Astragalus polysaccharides as carriers for improving biopharmaceutical properties of Astragalus flavonoids. Int J Nanomedicine 2023; 18:6705-24.

[251]

Li ZQ, Tian S, Gu H, Wu Z, Nyagblordzro M, Feng G, et al. In vitro-in vivo predictive dissolution-permeation-absorption dynamics of highly permeable drug extended-release tablets via drug dissolution/absorption simulating system and pH alteration. AAPS PharmSciTech 2018; 19(4):1882-93.

RIGHTS & PERMISSIONS

THE AUTHOR

PDF (5151KB)

25753

Accesses

0

Citation

Detail

Sections
Recommended

/